<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="cms" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">cms</book-part-id>
      <title-group>
        <title>Congenital Myasthenic Syndromes</title>
        <alt-title alt-title-type="alt-title">Synonym: Congenital Myasthenia</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Abicht</surname>
            <given-names>Angela</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Neurology<break/>Friedrich-Baur Institute<break/>Munich, Germany<break/>Medical Genetics Center (MGZ)<break/>Munich, Germany</aff>
          <email>angela.abicht@mgz-muenchen.de</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>M&#x000fc;ller</surname>
            <given-names>Juliane</given-names>
            <suffix>S</suffix>
          </name>
          <degrees>PhD</degrees>
          <aff>John Walton Muscular Dystrophy Research Centre<break/>Institute of Genetic Medicine<break/>Newcastle University<break/>Newcastle upon Tyne, United Kingdom</aff>
          <email>juliane.mueller@newcastle.ac.uk</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lochm&#x000fc;ller</surname>
            <given-names>Hanns</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>John Walton Muscular Dystrophy Research Centre<break/>Institute of Genetic Medicine<break/>Newcastle University<break/>Newcastle upon Tyne, United Kingdom</aff>
          <email>hanns.lochmuller@ncl.ac.uk</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>9</day>
          <month>5</month>
          <year>2003</year>
        </date>
        <date date-type="updated">
          <day>14</day>
          <month>7</month>
          <year>2016</year>
        </date>
        <date date-type="revised">
          <day>28</day>
          <month>6</month>
          <year>2012</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="cmd-overview" document-type="chapter">Congenital Muscular Dystrophy Overview</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="csc-dys" document-type="chapter">Congenital Stromal Corneal Dystrophy</related-object>
      <abstract id="cms.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Congenital myasthenic syndromes (designated as CMS throughout this entry) are characterized by fatigable weakness of skeletal muscle (e.g., ocular, bulbar, limb muscles) with onset at or shortly after birth or in early childhood; rarely, symptoms may not manifest until later in childhood. Cardiac and smooth muscle are usually not involved. Severity and course of disease are highly variable, ranging from minor symptoms to progressive disabling weakness. In some subtypes of CMS, myasthenic symptoms may be mild, but sudden severe exacerbations of weakness or even sudden episodes of respiratory insufficiency may be precipitated by fever, infections, or excitement. Major findings of the neonatal-onset subtype include: respiratory insufficiency with sudden apnea and cyanosis; feeding difficulties; poor suck and cry; choking spells; eyelid ptosis; and facial, bulbar, and generalized weakness. Arthrogryposis multiplex congenita may also be present. Stridor in infancy may be an important clue to CMS. Later childhood-onset subtypes show abnormal muscle fatigability with difficulty in activities such as running or climbing stairs; motor milestones may be delayed; fluctuating eyelid ptosis and fixed or fluctuating extraocular muscle weakness are common presentations.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of CMS is based on clinical findings, a decremental EMG response of the compound muscle action potential (CMAP) on low-frequency (2-3 Hz) stimulation, a positive response to acetylcholinesterase (AchE) inhibitors, absence of anti-acetylcholine receptor (AChR) and anti-MuSK antibodies in the serum, and lack of improvement of clinical symptoms with immunosuppressive therapy. Pathogenic variants in one of multiple genes encoding proteins expressed at the neuromuscular junction are currently known to be associated with subtypes of CMS. The most commonly associated genes include: <italic toggle="yes">CHAT</italic>, <italic toggle="yes">CHRNE</italic>, <italic toggle="yes">COLQ</italic>, <italic toggle="yes">DOK7</italic>, <italic toggle="yes">GFPT</italic>, and <italic toggle="yes">RAPSN</italic>.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Most individuals with CMS benefit from AChE inhibitors and/or the potassium channel blocker 3,4-diaminopyridine (3,4-DAP); however, caution must be used in giving 3,4-DAP to young children and individuals with fast-channel CMS (FCCMS). Individuals with <italic toggle="yes">COLQ</italic> and <italic toggle="yes">DOK7</italic> pathogenic variants usually do not respond to long-term treatment with AChE inhibitors. Some individuals with slow-channel CMS (SCCMS) are treated with quinidine, which has some major side effects and may be detrimental in individuals with AChR deficiency. Fluoxetine is reported to be beneficial for SCCMS. Ephedrine and albuterol have been beneficial in several individuals, especially as a therapeutic option for those with <italic toggle="yes">DOK7</italic> or <italic toggle="yes">COLQ</italic> pathogenic variants.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Prophylactic anticholinesterase therapy to prevent sudden respiratory insufficiency or apneic attacks provoked by fever or infections in those with pathogenic variants in <italic toggle="yes">CHAT</italic> or <italic toggle="yes">RAPSN</italic>. Parents of infants are advised to use apnea monitors and be trained in CPR.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Drugs known to affect neuromuscular transmission and exacerbate symptoms of myasthenia gravis (e.g., ciprofloxacin, chloroquine, procaine, lithium, phenytoin, beta-blockers, procainamide, quinidine).</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> If the pathogenic variants in the family are known, molecular genetic testing can be used to clarify the genetic status of at-risk asymptomatic family members, especially newborns or young children, who could benefit from early treatment to prevent sudden respiratory failure.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Congenital myasthenic syndromes are inherited in an autosomal recessive or an autosomal dominant manner.</p>
          <p>In autosomal recessive CMS (AR-CMS), the parents of an affected child are obligate heterozygotes and therefore carry one pathogenic variant. Heterozygotes (carriers) are asymptomatic. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
          <p>In autosomal dominant CMS (AD-CMS), some individuals have an affected parent while others have a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by <italic toggle="yes">de novo</italic> pathogenic variants is unknown. Each child of an individual with AD-CMS has a 50% chance of inheriting the pathogenic variant.</p>
          <p>Prenatal testing and preimplantation genetic diagnosis are possible if the pathogenic variant(s) have been identified in an affected family member.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="cms.Diagnosis">
        <title>Diagnosis</title>
        <sec id="cms.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Congenital myasthenic syndromes (CMS) <bold>should be suspected</bold> in individuals with the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>A history of fatigable weakness involving ocular, bulbar, and limb muscles with onset at or shortly after birth or in early childhood. Post-childhood onset has been observed, but is rare [<xref ref-type="bibr" rid="cms.REF.burke.2003.826">Burke et al 2003</xref>, <xref ref-type="bibr" rid="cms.REF.beeson.2005.498">Beeson et al 2005</xref>, <xref ref-type="bibr" rid="cms.REF.m_ller.2007a.1497">M&#x000fc;ller et al 2007a</xref>].</p>
            </list-item>
            <list-item>
              <p>A decremental EMG response of the compound muscle action potential (CMAP) on low-frequency (2-3 Hz) stimulation (see <xref ref-type="sec" rid="cms.Testing">Testing</xref>, <bold>Electrophysiologic testing</bold>)</p>
            </list-item>
            <list-item>
              <p>A positive response to acetylcholinesterase (AchE) inhibitors(see <xref ref-type="sec" rid="cms.Testing">Testing</xref>, <bold>Response to acetylcholinesterase inhibitors</bold>)</p>
            </list-item>
            <list-item>
              <p>Absence of anti-acetylcholine receptor (anti-AChR) and anti-MuSK antibodies in the serum</p>
              <p>Note: (1) Absence of anti-AChR antibodies in the serum can help distinguish CMS from myasthenia gravis (MG), but does not exclude seronegative types of MG or MG with anti-MuSK antibodies [<xref ref-type="bibr" rid="cms.REF.hoch.2001.365">Hoch et al 2001</xref>]. (2) One case of autoimmune MG developing in an individual with CMS has been reported [<xref ref-type="bibr" rid="cms.REF.croxen.2002b.1563">Croxen et al 2002b</xref>].</p>
            </list-item>
            <list-item>
              <p>Lack of improvement of clinical symptoms with immunosuppressive therapy</p>
            </list-item>
            <list-item>
              <p>Absence of major pathology in a skeletal muscle biopsy specimen despite considerable muscle weakness</p>
            </list-item>
            <list-item>
              <p>A family history consistent with either autosomal recessive or autosomal dominant inheritance</p>
            </list-item>
          </list>
          <sec id="cms.Testing">
            <title>Testing</title>
            <p>
              <bold>Laboratory testing</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Serum creatine kinase (CK) concentration may be normal or slightly elevated (usually not more than tenfold the normal).</p>
              </list-item>
              <list-item>
                <p>Anti-AChR and anti-MuSK antibody testing (serum) is negative.</p>
              </list-item>
            </list>
            <p>
              <bold>Electrophysiologic testing</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Generally, individuals should be tested for a decremental EMG response of the CMAP on low-frequency (2- to 3-Hz) stimulation.</p>
              </list-item>
              <list-item>
                <p>In some cases, 2- to 3-Hz stimulation elicits no decremental response from rested non-weak muscle, but elicits a significant decremental response after five to ten minutes of stimulation at 10 Hz.</p>
              </list-item>
              <list-item>
                <p>If the amplitude of the CMAP is normal in two distal and two proximal muscles, facial muscles should be tested.</p>
              </list-item>
              <list-item>
                <p>Alternatively or in addition, a single-fiber EMG is a good determinant of a neuromuscular transmission defect.</p>
              </list-item>
              <list-item>
                <p>A single nerve stimulus may elicit a repetitive CMAP (the so-called &#x0201c;double response to single nerve stimulus&#x0201d;) in individuals with endplate AChE deficiency or slow-channel CMS (SCCMS; caused by autosomal dominant gain-of-function variants of the genes encoding the AChR subunits that prolong the time that the AChR channel is open), or in those taking high doses of AChE inhibitors.</p>
              </list-item>
            </list>
            <p><bold>Response to AChE inhibitors</bold> may be assessed by using intravenous injection of edrophonium (Tensilon<sup>&#x000ae;</sup>), a fast-acting AChE inhibitor, or by a controlled/supervised trial of oral AChE inhibitors.</p>
            <p>Intravenous application of edrophonium chloride (known as Tensilon<sup>&#x000ae;</sup> test) must be performed under intensive care conditions. In adults with bodyweight higher than 30 kilograms, an initial dose of 2.0 mg is injected over 15 seconds, followed by additional doses of 3.0 mg and 5.0 mg at intervals of 60 seconds, if necessary. In newborns and infants, dosage varies [<xref ref-type="bibr" rid="cms.REF.schara.2012.184">Schara et al 2012</xref>]. Maximum improvement occurs within 30 seconds of the injection and persists for minutes. An objective endpoint (e.g., improvement in ptosis, extraocular muscle weakness, tongue weakness, decremental EMG response) needs to be established prior to the injection and then carefully followed.</p>
            <p>Alternatively, a controlled/supervised trial of oral medication with AChE inhibitor is possible. This may be helpful in patients with fatigable muscle weakness but no obvious clinical symptoms (e.g., ptosis, bulbar weakness) that can be easily monitored.</p>
            <p><bold>Morphologic studies.</bold> Conventional skeletal muscle biopsy and routine histochemical studies in individuals with CMS generally show no major abnormalities except for type I fiber predominance and occasionally minor myopathic changes. Note: Tubular aggregates have been described in <italic toggle="yes">GFPT1</italic>-associated limb-girdle CMS [<xref ref-type="bibr" rid="cms.REF.senderek.2011.162">Senderek et al 2011</xref>] and dystrophic changes can be found in patients with <italic toggle="yes">GMPPB</italic> pathogenic variants [<xref ref-type="bibr" rid="cms.REF.belaya.2015.2493">Belaya et al 2015</xref>].</p>
          </sec>
        </sec>
        <sec id="cms.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of CMS <bold>is established</bold> in a proband with the findings <xref ref-type="sec" rid="cms.Suggestive_Findings">above</xref> in combination with the identification of a heterozygous or biallelic pathogenic variant(s) in one of the genes listed in <xref ref-type="table" rid="cms.T.molecular_genetics_of_congenital_m">Table 1a</xref> and <xref ref-type="table" rid="cms.T.molecular_genetics_congenital_myas">Table 1b</xref>; these genes, encoding different proteins expressed at the neuromuscular junction, are currently known to be associated with CMS [<xref ref-type="bibr" rid="cms.REF.hanta_.2013.561">Hanta&#x000ef; et al 2013</xref>, <xref ref-type="bibr" rid="cms.REF.rodr_guez_cruz.2014.2234">Rodr&#x000ed;guez Cruz et al 2014</xref>, <xref ref-type="bibr" rid="cms.REF.engel.2015.461">Engel et al 2015</xref>].</p>
          <p>Molecular testing approaches can include <bold>serial single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>.</p>
          <p><bold>Serial single-gene testing</bold> has been considered as first-tier testing if (1) mutation of a particular gene accounts for a large proportion of the disease (see <xref ref-type="table" rid="cms.T.molecular_genetics_of_congenital_m">Table 1a</xref>) <bold>or</bold> (2) factors including clinical findings, laboratory findings, and ancestry indicate that mutation of a particular gene is most likely.</p>
          <p>Sequence analysis of the gene of interest is performed first, followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found.</p>
          <p>Some clinical clues may help the clinician pinpoint the gene most likely to be involved:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Apneas.</bold> Perform molecular genetic testing of <italic toggle="yes">RAPSN</italic>, <italic toggle="yes">CHAT</italic>, and <italic toggle="yes">COLQ</italic>.</p>
            </list-item>
            <list-item>
              <p><bold>No response to treatment with AChE inhibitors.</bold> Consider testing for pathogenic variants in <italic toggle="yes">COLQ</italic>.</p>
            </list-item>
            <list-item>
              <p><bold>Double response to a single nerve stimulus.</bold> Consider:</p>
              <list list-type="bullet">
                <list-item>
                  <p>A pathogenic variant in <italic toggle="yes">COLQ</italic>;</p>
                  <p>OR</p>
                </list-item>
                <list-item>
                  <p>A slow-channel CMS with a pathogenic variant in one of the genes encoding the AChR subunits (<italic toggle="yes">CHRNA1</italic>, <italic toggle="yes">CHRNB1</italic>, <italic toggle="yes">CHRND</italic>, <italic toggle="yes">CHRNE</italic>).</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Incremental response in CMAP amplitude following maximum voluntary contraction.</bold> Consider testing for pathogenic variant in <italic toggle="yes">SYT2.</italic></p>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">Pes cavus</italic> and hammer toes.</bold> Consider testing for pathogenic variant in <italic toggle="yes">SYT2.</italic></p>
            </list-item>
            <list-item>
              <p><bold>Contractures.</bold> Consider testing for pathogenic variant in <italic toggle="yes">RAPSN</italic>.</p>
            </list-item>
            <list-item>
              <p><bold>Autosomal dominant family history.</bold> Consider slow-channel CMS caused by pathogenic variants in the genes encoding AChR subunits: <italic toggle="yes">CHRNA1</italic>, <italic toggle="yes">CHRNB1</italic>, <italic toggle="yes">CHRND</italic>, <italic toggle="yes">CHRNE</italic> or SYT2-associated CMS.</p>
            </list-item>
          </list>
          <p>Targeted analysis for pathogenic variants may be carried out first depending on the ethnic origin of the individual:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>German</bold> or <bold>central/western European origin.</bold>
<italic toggle="yes">RAPSN</italic> pathogenic variant <xref ref-type="table" rid="cms.T.selected_rapsn_pathogenic_variants">c.264C&#x0003e;A</xref> and <italic toggle="yes">DOK7</italic> pathogenic variant <xref ref-type="table" rid="cms.T.selected_dok7_pathogenic_variants">c.1124_1127dupTGCC</xref></p>
            </list-item>
            <list-item>
              <p><bold>Southeastern European</bold> or <bold>Roma origin.</bold>
<italic toggle="yes">CHRNE</italic> pathogenic variant <xref ref-type="table" rid="cms.T.selected_chrne_pathogenic_variants">c.1327delG</xref></p>
            </list-item>
            <list-item>
              <p><bold>From the Maghreb</bold> (especially Algeria and Tunisia). <italic toggle="yes">CHRNE</italic> pathogenic variant <xref ref-type="table" rid="cms.T.selected_chrne_pathogenic_variants">c.1353dupG</xref></p>
            </list-item>
            <list-item>
              <p><bold>From Spain or</bold>
<bold>Portugal.</bold>
<italic toggle="yes">CHRNE</italic> pathogenic variant <xref ref-type="table" rid="cms.T.selected_chrne_pathogenic_variants">c.130dupG</xref></p>
            </list-item>
          </list>
          <p><bold>A multi-gene panel</bold> that includes the genes from <xref ref-type="table" rid="cms.T.molecular_genetics_of_congenital_m">Table 1a</xref> and <xref ref-type="table" rid="cms.T.molecular_genetics_congenital_myas">Table 1b</xref> and other genes of interest (see <xref ref-type="sec" rid="cms.Differential_Diagnosis">Differential Diagnosis</xref>) may be considered as first- or second-tier option; due to the genetic heterogeneity of CMS, a multi-gene panel using next-generation sequencing technologies is emerging as a first-tier test. Note: The genes included and the sensitivity of multi-gene panels vary by laboratory and over time.</p>
          <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel that includes the genes listed in <xref ref-type="table" rid="cms.T.molecular_genetics_of_congenital_m">Table 1a</xref> and <xref ref-type="table" rid="cms.T.molecular_genetics_congenital_myas">Table 1b</xref>) fails to confirm a diagnosis in an individual with features of CMS. Such testing may provide an unexpected or previously unconsidered diagnosis, such as mutation in another gene that causes a similar clinical presentation. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
          <table-wrap id="cms.T.molecular_genetics_of_congenital_m" orientation="portrait" position="anchor">
            <label>Table 1a. </label>
            <caption>
              <p>Molecular Genetics of Congenital Myasthenic Syndromes: Most Common Genetic Causes</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_1">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th>
                  <th id="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_2">% of CMS Attributed to Pathogenic Variants in This Gene</th>
                  <th id="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detected by Test Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3" id="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Sequence analysis&#x000a0;<sup>4</sup></th>
                  <th headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3" id="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">CHAT</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">4%-5%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">~100%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">CHRNE</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">50%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">~99%&#x000a0;<sup>7,&#x000a0;8,&#x000a0;9</sup></td>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6</sup>, but in single cases reported&#x000a0;<sup>9</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">COLQ</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">10%-15%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">~100%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">DOK7</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">10%-15%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">~100%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">GFPT1</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">2%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">~100%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">RAPSN</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">15%-20%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">~85%&#x000a0;<sup>10</sup></td>
                  <td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Up to 15%&#x000a0;<sup>11</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Pathogenic variants of any one of the genes included in this table account for &#x0003e;1% of CMS</p>
              </fn>
              <fn id="cms.TF.1a.1">
                <label>1. </label>
                <p>Genes are listed in alphabetic order.</p>
              </fn>
              <fn id="cms.TF.1a.2">
                <label>2. </label>
                <p>See <related-object source-id="gene" document-id="cms" object-id="cms.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="cms.TF.1a.3">
                <label>3. </label>
                <p>See <xref ref-type="sec" rid="cms.Molecular_Genetics">Molecular Genetics</xref> for information on pathogenic allelic variants detected.</p>
              </fn>
              <fn id="cms.TF.1a.4">
                <label>4. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="cms.TF.1a.5">
                <label>5. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="cms.TF.1a.6">
                <label>6. </label>
                <p>No data on detection rate of gene-targeted deletion/duplication analysis are available.</p>
              </fn>
              <fn id="cms.TF.1a.7">
                <label>7. </label>
                <p>The <italic toggle="yes">CHRNE</italic> founder pathogenic variant <xref ref-type="table" rid="cms.T.selected_chrne_pathogenic_variants">c.1327delG</xref> in exon 12 is present in up to 50% of individuals of European Roma and/or southeastern European origin with CMS [<xref ref-type="bibr" rid="cms.REF.abicht.1999.1564">Abicht et al 1999</xref>, <xref ref-type="bibr" rid="cms.REF.karcagi.2001.231">Karcagi et al 2001</xref>].</p>
              </fn>
              <fn id="cms.TF.1a.8">
                <label>8. </label>
                <p>The <italic toggle="yes">CHRNE</italic> founder pathogenic variant <xref ref-type="table" rid="cms.T.selected_chrne_pathogenic_variants">c.1353dupG</xref> is present in up to 20% of persons from the Maghreb (especially Algeria and Tunisia) [<xref ref-type="bibr" rid="cms.REF.beeson.2005.498">Beeson et al 2005</xref>].</p>
              </fn>
              <fn id="cms.TF.1a.9">
                <label>9. </label>
                <p>
                  <xref ref-type="bibr" rid="cms.REF.abicht.2002.1005">Abicht et al [2002]</xref>
                </p>
              </fn>
              <fn id="cms.TF.1a.10">
                <label>10. </label>
                <p>Most affected individuals of European origin, especially those with respiratory failure, have the <xref ref-type="table" rid="cms.T.selected_rapsn_pathogenic_variants">c.264C&#x0003e;A</xref> pathogenic variant on at least one allele; about 50% are homozygous for c.264C&#x0003e;A.</p>
              </fn>
              <fn id="cms.TF.1a.11">
                <label>11. </label>
                <p><xref ref-type="bibr" rid="cms.REF.m_ller.2004a.e104">M&#x000fc;ller et al [2004a]</xref>, <xref ref-type="bibr" rid="cms.REF.gaudon.2010.795">Gaudon et al [2010]</xref>.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <table-wrap id="cms.T.molecular_genetics_congenital_myas" orientation="portrait" position="anchor">
            <label>Table 1b. </label>
            <caption>
              <p>Molecular Genetics Congenital Myasthenic Syndromes: Less Common Genetic Causes</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1,&#x000a0;2,&#x000a0;3,&#x000a0;4</sup></th>
                  <th id="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">% of CMS Attributed to Pathogenic Variants in This Gene</th>
                  <th id="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Comment</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">AGRN</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Reported in 7 families [<xref ref-type="bibr" rid="cms.REF.huz_.2009.155">Huz&#x000e9; et al 2009</xref>, <xref ref-type="bibr" rid="cms.REF.maselli.2012.1123">Maselli et al 2012</xref>, <xref ref-type="bibr" rid="cms.REF.karakaya.2014">Karakaya et al 2014</xref>, <xref ref-type="bibr" rid="cms.REF.nicole.2014.2429">Nicole et al 2014</xref>]</td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">ALG2</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cms.REF.cossins.2013.944">Cossins et al [2013]</xref>, <xref ref-type="bibr" rid="cms.REF.monies.2014.353">Monies et al [2014]</xref></td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">ALG14</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="cms.REF.cossins.2013.944">Cossins et al [2013]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">CHRNA1</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Several patients reported w/AD or AR variants [<xref ref-type="bibr" rid="cms.REF.croxen.1997.767">Croxen et al 1997</xref>, <xref ref-type="bibr" rid="cms.REF.rodr_guez_cruz.2014.2234">Rodr&#x000ed;guez Cruz et al 2014</xref>]</td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">CHRNB1</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="cms.REF.quiram.1999.1403">Quiram et al [1999]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">CHRND</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="cms.REF.m_ller.2006.2784">M&#x000fc;ller et al [2006]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">COL13A1</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="cms.REF.logan.2015.878">Logan et al [2015]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">DPAGT1</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Several patients reported [<xref ref-type="bibr" rid="cms.REF.belaya.2012a.29">Belaya et al 2012a</xref>, <xref ref-type="bibr" rid="cms.REF.belaya.2012b.193">Belaya et al 2012b</xref>, <xref ref-type="bibr" rid="cms.REF.basiri.2013.469">Basiri et al 2013</xref>, <xref ref-type="bibr" rid="cms.REF.selcen.2014.1822">Selcen et al 2014</xref>]</td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">GMPPB</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="cms.REF.belaya.2015.2493">Belaya et al [2015]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">LAMB2</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Reported in 1 individual w/concomitant renal failure [<xref ref-type="bibr" rid="cms.REF.maselli.2009.203">Maselli et al 2009</xref>]</td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">LRP4</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2 CMS kinships reported [<xref ref-type="bibr" rid="cms.REF.ohkawara.2014.1856">Ohkawara et al 2014</xref>, <xref ref-type="bibr" rid="cms.REF.selcen.2015.889">Selcen et al 2015</xref>]</td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">MUSK</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Reported in 8 individuals from 3 families [<xref ref-type="bibr" rid="cms.REF.chevessier.2004.3229">Chevessier et al 2004</xref>, <xref ref-type="bibr" rid="cms.REF.mihaylova.2009.1926">Mihaylova et al 2009</xref>, <xref ref-type="bibr" rid="cms.REF.maselli.2010.2370">Maselli et al 2010</xref>]</td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">MYO9A</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Authors, personal observation</td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">PLEC</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cms.REF.forrest.2010.709">Forrest et al [2010]</xref>, <xref ref-type="bibr" rid="cms.REF.selcen.2011.327">Selcen et al [2011]</xref>, <xref ref-type="bibr" rid="cms.REF.fattahi.2015.60">Fattahi et al [2015]</xref></td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">PREPL</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="cms.REF.r_gal.2014.1254">R&#x000e9;gal et al [2014]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">SCN4A</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Reported in 2 unrelated individuals [<xref ref-type="bibr" rid="cms.REF.tsujino.2003.7377">Tsujino et al 2003</xref>, <xref ref-type="bibr" rid="cms.REF.habbout.2016.161">Habbout et al 2016</xref>]</td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">SLC25A1</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR variants reported in 2 affected sibs [<xref ref-type="bibr" rid="cms.REF.chaouch.2014.75">Chaouch et al 2014</xref>]</td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">SLC5A7</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Authors, personal observation</td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">SNAP25</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">De novo</italic> AD variant in 1 patient with w/myasthenia &#x00026; multiple contractures at birth, cortical hyperexcitability, cerebellar ataxia, &#x00026; severe intellectual disability [<xref ref-type="bibr" rid="cms.REF.shen.2014.2247">Shen et al 2014</xref>]</td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">SYT2</italic>
                  </td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD variants in 2 multigenerational families w/foot deformities, fatigable ocular &#x00026; lower limb weakness, &#x00026; response to modulators of acetylcholine release [<xref ref-type="bibr" rid="cms.REF.herrmann.2014.332">Herrmann et al 2014</xref>, <xref ref-type="bibr" rid="cms.REF.whittaker.2015.1964">Whittaker et al 2015</xref>]</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Pathogenic variants of any one of the genes listed in this table are reported in only a few families (i.e., &#x0003c;1% of CMS)</p>
              </fn>
              <fn>
                <p>AD = autosomal dominant</p>
              </fn>
              <fn>
                <p>AR = autosomal recessive</p>
              </fn>
              <fn id="cms.TF.1b.1">
                <label>1. </label>
                <p>Genes are listed in alphabetic order.</p>
              </fn>
              <fn id="cms.TF.1b.2">
                <label>2. </label>
                <p>See <related-object source-id="gene" document-id="cms" object-id="cms.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="cms.TF.1b.3">
                <label>3. </label>
                <p>Genes are not described in detail in Molecular Genetics, but may be included <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="cms-less_common_genes.pdf" content-type="local-data">here</inline-supplementary-material> (pdf).</p>
              </fn>
              <fn id="cms.TF.1b.4">
                <label>4. </label>
                <p>Other subtypes of CMS have been reported in the literature in a few kinships without identification of the underlying genetic defect [<xref ref-type="bibr" rid="cms.REF.engel.2015.461">Engel et al 2015</xref>]. A proportion of individuals with CMS remain without molecular genetic diagnosis even after exome studies, suggesting the involvement of additional, as-yet unidentified genes in CMS.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="cms.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="cms.Clinical_Description">
          <title>Clinical Description</title>
          <p><bold>Onset.</bold> In the congenital myasthenic syndromes (CMS), the first myasthenic symptoms occur in general early in life, usually in the first two years. Rarely, onset is in the second to third decade of life [<xref ref-type="bibr" rid="cms.REF.milone.1999.a188">Milone et al 1999</xref>, <xref ref-type="bibr" rid="cms.REF.croxen.2002a.162">Croxen et al 2002a</xref>, <xref ref-type="bibr" rid="cms.REF.burke.2003.826">Burke et al 2003</xref>, <xref ref-type="bibr" rid="cms.REF.m_ller.2007a.1497">M&#x000fc;ller et al 2007a</xref>, <xref ref-type="bibr" rid="cms.REF.croxen.2009.294">Croxen et al 2009</xref>, <xref ref-type="bibr" rid="cms.REF.ben_ammar.2010.754">Ben Ammar et al 2010</xref>, <xref ref-type="bibr" rid="cms.REF.guergueltcheva.2012.838">Guergueltcheva et al 2012</xref>].</p>
          <p><bold>Neuromuscular findings.</bold> CMS is limited to weakness of the skeletal muscles. Cardiac and smooth muscle are usually not involved. Coordination, sensation, and tendon reflexes are normal; cognitive skills are usually normal.</p>
          <p><bold>Neonatal presentation.</bold> Some myasthenic symptoms are present at birth.</p>
          <list list-type="bullet">
            <list-item>
              <p>Respiratory insufficiency with sudden apnea and cyanosis are common findings in neonates.</p>
            </list-item>
            <list-item>
              <p>Neonates with CMS can have multiple joint contractures (often described as arthrogryposis multiplex congenita [AMC]) resulting from a lack of fetal movement in utero.</p>
            </list-item>
            <list-item>
              <p>Other major findings in the neonatal period may include feeding difficulties, poor suck and cry, choking spells, eyelid ptosis, and facial, bulbar, and generalized weakness. Stridor in infancy may be an important clue to CMS [<xref ref-type="bibr" rid="cms.REF.kinali.2008.6">Kinali et al 2008</xref>].</p>
            </list-item>
          </list>
          <p><bold>Childhood presentation.</bold> Individuals with onset later in childhood show abnormal muscle fatigability, with difficulty in running or climbing stairs.</p>
          <list list-type="bullet">
            <list-item>
              <p>Motor milestones may be delayed.</p>
            </list-item>
            <list-item>
              <p>Affected individuals present with fluctuating eyelid ptosis and fixed or fluctuating extraocular muscle weakness. Ptosis may involve one or both eyelids.</p>
            </list-item>
            <list-item>
              <p>In addition, facial and bulbar weakness with nasal speech and difficulties in coughing and swallowing may be present.</p>
            </list-item>
            <list-item>
              <p>Spinal deformity or muscle atrophy may occur.</p>
            </list-item>
          </list>
          <p><bold>Limb girdle presentation.</bold> Some individuals display a characteristic &#x02018;limb-girdle&#x02019; pattern of weakness with ptosis and a waddling gait, with or without ptosis and ophthalmoparesis (&#x02018;limb girdle myasthenia&#x02019;).</p>
          <p><bold>Dysmorphic features.</bold> In some individuals, long face, narrow jaw, and a high-arched palate have been reported [<xref ref-type="bibr" rid="cms.REF.burke.2004.356">Burke et al 2004</xref>].</p>
          <p><bold>Cognitive skills.</bold> The vast majority of individuals with CMS have normal cognitive skills. Recently, three patients have been reported with <italic toggle="yes">DPAGT1</italic>-associated CMS and intellectual disability [<xref ref-type="bibr" rid="cms.REF.selcen.2014.1822">Selcen et al 2014</xref>]. Severe intellectual disability appears to be a feature of <italic toggle="yes">SNAP25-</italic>associated CMS [<xref ref-type="bibr" rid="cms.REF.shen.2014.2247">Shen et al 2014</xref>].</p>
          <p><bold>Prognosis.</bold> Severity and course of disease are highly variable, ranging from minor symptoms (e.g., mild exercise intolerance) to progressive disabling weakness. Minor myasthenic symptoms may be exacerbated by sudden onset of severe weakness or respiratory insufficiency precipitated by fever, infections, or excitement especially in individuals with CMS with episodic apnea (CMS-EA) or endplate rapsyn deficiency [<xref ref-type="bibr" rid="cms.REF.ohno.2001.2017">Ohno et al 2001</xref>, <xref ref-type="bibr" rid="cms.REF.byring.2002.548">Byring et al 2002</xref>, <xref ref-type="bibr" rid="cms.REF.ohno.2002.875">Ohno et al 2002</xref>].</p>
        </sec>
        <sec id="cms.Phenotype_Correlations_by_Gene">
          <title>Phenotype Correlations by Gene</title>
          <p>Major CMS subtypes are recognized based on molecular genetic studies [<xref ref-type="bibr" rid="cms.REF.finlayson.2013.80">Finlayson et al 2013</xref>, <xref ref-type="bibr" rid="cms.REF.engel.2015.461">Engel et al 2015</xref>] (see <xref ref-type="table" rid="cms.T.cms_subtypes_by_gene_involved">Table 2</xref>).</p>
          <table-wrap id="cms.T.cms_subtypes_by_gene_involved" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>CMS Subtypes by Gene Involved</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene(s) Associated with Disease</th>
                  <th id="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">CMS Subtype</th>
                  <th id="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Clinical Findings&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Response to AChE Inhibitors&#x000a0;<sup>2</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">CHAT</italic>
                  </td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">CMS w/episodic apnea</td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Hypotonia, respiratory failure at birth</p></list-item><list-item><p>Episodic apnea</p></list-item><list-item><p>Improvement w/age</p></list-item></list>
</td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Improvement</td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">AChR subunit genes:
<list list-type="bullet"><list-item><p><italic toggle="yes">CHRNE</italic></p></list-item></list>
CHRNA1
<list list-type="bullet"><list-item><p><italic toggle="yes">CHRNB1</italic></p></list-item><list-item><p><italic toggle="yes">CHRND</italic></p></list-item></list>
</td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Acetylcholine receptor deficiency</td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Early onset</p></list-item><list-item><p>Varies from mild to severe</p></list-item><list-item><p>Ptosis, EOP&#x000a0;<sup>3</sup>; bulbar, arm, leg weakness</p></list-item></list>
</td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Improvement</td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Slow-channel CMS</td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Selective severe neck, wrist, finger extensor weakness</p></list-item><list-item><p>Childhood to adult onset</p></list-item><list-item><p>Varies from mild to severe</p></list-item><list-item><p>Progressive ventilatory insufficiency; may require assisted ventilation</p></list-item></list>
</td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Often deterioration</td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Fast-channel CMS</td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Varies from mild to severe</td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Improvement</td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">COLQ</italic>
                  </td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Endplate AChE deficiency</td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Often severe</p></list-item><list-item><p>In some w/C-terminal missense pathogenic variants: later presentation, milder clinical course</p></list-item><list-item><p>EOP</p></list-item><list-item><p>General muscle weakness / severe involvement of axial muscles</p></list-item><list-item><p>Slow pupillary light response</p></list-item></list>
</td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Deterioration or no response</td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">DOK7</italic>
                  </td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">DOK7-associated limb-girdle-myasthenia</td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Limb-girdle pattern of weakness w/predominantly proximal weakness, waddling gait, &#x00026; ptosis but no EOP</td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Deterioration or no response</td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">RAPSN</italic>
                  </td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Endplate rapsyn deficiency</td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Early onset:
<list list-type="bullet"><list-item><p>Hypotonia, respiratory failure at birth</p></list-item><list-item><p>Episodic apnea</p></list-item><list-item><p>Arthrogryposis multiplex congenita</p></list-item><list-item><p>Varies from mild to severe</p></list-item></list>
Late onset:
<list list-type="bullet"><list-item><p>Limb weakness in adolescence or adulthood resembling seronegative myasthenia gravis</p></list-item></list>
</td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Improvement</td>
                </tr>
                <tr>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">GFPT1, DPAGT1, ALG2</italic>, <italic toggle="yes">ALG14, GMPPB, PREPL</italic></td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Limb-girdle-myasthenia w/glycosylation deficiency</td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0201c;Limb-girdle&#x0201d; pattern of weakness w/predominantly proximal weakness but usually no ptosis or EOP; sometimes tubular aggregates in muscle biopsy&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Improvement</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Includes only those genes for which more than a few individuals/families have been reported</p>
              </fn>
              <fn id="cms.TF.2.1">
                <label>1. </label>
                <p>Because of the many private pathogenic variants and the limited number of genotype-phenotype correlations, the clinical spectrum may be broader or different from the findings listed.</p>
              </fn>
              <fn id="cms.TF.2.2">
                <label>2. </label>
                <p>See Diagnosis, <xref ref-type="sec" rid="cms.Testing">Testing</xref>, <bold>Response to acetylcholinesterase inhibitors</bold>.</p>
              </fn>
              <fn id="cms.TF.2.3">
                <label>3. </label>
                <p>EOP = external ophthalmoplegia</p>
              </fn>
              <fn id="cms.TF.2.4">
                <label>4. </label>
                <p><xref ref-type="bibr" rid="cms.REF.senderek.2011.162">Senderek et al [2011]</xref>, <xref ref-type="bibr" rid="cms.REF.guergueltcheva.2012.838">Guergueltcheva et al [2012]</xref></p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="cms.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Pathogenic variants in the genes encoding the AChR subunits (<italic toggle="yes">CHRNA1, CHRNB1, CHRND, CHRNE</italic>) can be inherited in an autosomal dominant or autosomal recessive manner.</p>
          <list list-type="bullet">
            <list-item>
              <p>Gain-of-function variants in <italic toggle="yes">CHRNA1</italic>, <italic toggle="yes">CHRNB1, CHRND</italic>, or <italic toggle="yes">CHRNE</italic> that alter the kinetic properties of the AChR result in the autosomal dominant slow channel CMS (SCCMS) [<xref ref-type="bibr" rid="cms.REF.engel.2003.339">Engel et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p>Loss-of-function variants in the AChR subunit genes (<italic toggle="yes">CHRNA1, CHRNB1, CHRND, CHRNE</italic>) are associated with autosomal recessive CMS [<xref ref-type="bibr" rid="cms.REF.hanta_.2004.539">Hanta&#x000ef; et al 2004</xref>, <xref ref-type="bibr" rid="cms.REF.ohno.2004a.117">Ohno &#x00026; Engel 2004a</xref>, <xref ref-type="bibr" rid="cms.REF.engel.2005.308">Engel &#x00026; Sine 2005</xref>].</p>
            </list-item>
            <list-item>
              <p>Some clinical clues point to specific genetic defects [<xref ref-type="bibr" rid="cms.REF.abicht.2012.1474">Abicht et al 2012</xref>, <xref ref-type="bibr" rid="cms.REF.finlayson.2013.80">Finlayson et al 2013</xref>, <xref ref-type="bibr" rid="cms.REF.engel.2015.461">Engel et al 2015</xref>]. For example, arthrogryposis multiplex congenita [AMC]) appears to be particularly common in infants with truncating <italic toggle="yes">RAPSN</italic> pathogenic variants [<xref ref-type="bibr" rid="cms.REF.brownlow.2001.125">Brownlow et al 2001</xref>, <xref ref-type="bibr" rid="cms.REF.burke.2003.826">Burke et al 2003</xref>, <xref ref-type="bibr" rid="cms.REF.beeson.2005.498">Beeson et al 2005</xref>]. Stridor in infancy may occur in CMS, particularly in those with <italic toggle="yes">DOK7</italic> pathogenic variants [<xref ref-type="bibr" rid="cms.REF.kinali.2008.6">Kinali et al 2008</xref>]. See <xref ref-type="table" rid="cms.T.cms_subtypes_by_gene_involved">Table 2</xref> and <xref ref-type="sec" rid="cms.Establishing_the_Diagnosis">Establishing the Diagnosis</xref>.</p>
            </list-item>
          </list>
          <p>Genotype-phenotype correlations are difficult to establish for those rare CMS subtypes for which pathogenic variants have been identified in only a few patients worldwide.</p>
        </sec>
        <sec id="cms.Penetrance">
          <title>Penetrance</title>
          <p>In general, reported CMS pathogenic variants have complete penetrance.</p>
          <p>One case of reduced penetrance has been reported for slow-channel CMS (SCCMS) resulting from pathogenic variants in <italic toggle="yes">CHRNE</italic> [<xref ref-type="bibr" rid="cms.REF.croxen.2002a.162">Croxen et al 2002a</xref>, <xref ref-type="bibr" rid="cms.REF.croxen.2009.294">Croxen et al 2009</xref>].</p>
        </sec>
        <sec id="cms.Nomenclature">
          <title>Nomenclature</title>
          <p>An outdated and misleading term is familial infantile myasthenia (FIM) [<xref ref-type="bibr" rid="cms.REF.deymeer.1999.129">Deymeer et al 1999</xref>].</p>
        </sec>
        <sec id="cms.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of CMS is estimated at one tenth that of myasthenia gravis (which has a prevalence of 25:1,000,000-125:1,000,000); however, it may be higher. At least 1000 independent kinships with identified pathogenic variants have been documented worldwide [<xref ref-type="bibr" rid="cms.REF.chaouch.2012b.474">Chaouch et al 2012b</xref>].</p>
          <p>The population of the southeastern European Roma may be at higher risk for CMS because of an increased carrier rate (&#x0003e;4%) for the pathogenic variant <xref ref-type="table" rid="cms.T.selected_chrne_pathogenic_variants">c.1327delG</xref> in <italic toggle="yes">CHRNE,</italic> the gene encoding the &#x003b5;AChR subunit [<xref ref-type="bibr" rid="cms.REF.morar.2004.596">Morar et al 2004</xref>].</p>
          <p>Individuals from the Maghreb (especially Algeria and Tunisia) may be at higher risk for CMS because of another <italic toggle="yes">CHRNE</italic> founder pathogenic variant, <xref ref-type="table" rid="cms.T.selected_chrne_pathogenic_variants">c.1353dupG</xref> [<xref ref-type="bibr" rid="cms.REF.beeson.2005.498">Beeson et al 2005</xref>].</p>
        </sec>
      </sec>
      <sec id="cms.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold><italic toggle="yes">SCN4A.</italic></bold> Gain-of-function variants in this gene (encoding the sodium channel protein type 4 subunit alpha) have been identified in several disorders of muscle membrane excitability: potassium-aggravated myotonia, paramyotonia congenita, and <related-object link-type="booklink" source-id="gene" document-id="hyper-pp" document-type="chapter">hyperkalemic periodic paralysis</related-object> [<xref ref-type="bibr" rid="cms.REF.jurkatrott.2010.239">Jurkat-Rott et al 2010</xref>].</p>
        <p><bold>Fetal akinesia deformation sequence (FADS), prenatal CMS.</bold> Fetal hypomobility can result in the intrauterine phenotype of FADS, characterized by severe joint contractures, subcutaneous edema, growth retardation, lung hypoplasia, and other malformations. FADS has multiple etiologies and can be lethal or non-lethal. If multiple pterygia are present the phenotype is described as Escobar syndrome and biallelic pathogenic variants have been identified in the fetally expressed gamma subunit of AChR (<italic toggle="yes">CHRNG</italic>) [<xref ref-type="bibr" rid="cms.REF.ravenscroft.2011.793">Ravenscroft et al 2011</xref>]. For several CMS-related genes it has been demonstrated that biallelic variants with most severe functional effects (mainly null variants) result in the phenotype of FADS (&#x0201c;prenatal CMS&#x0201d;). So far, a FADS phenotype has been reported for variants in <italic toggle="yes">RAPSN</italic>, <italic toggle="yes">DOK7</italic>, <italic toggle="yes">CHRNA1</italic>, <italic toggle="yes">CHRNB1</italic>, <italic toggle="yes">CHRND</italic>, <italic toggle="yes">MUSK</italic>, <italic toggle="yes">DPAGT1</italic>) [<xref ref-type="bibr" rid="cms.REF.vogt.2008.222">Vogt et al 2008</xref>, <xref ref-type="bibr" rid="cms.REF.ravenscroft.2011.793">Ravenscroft et al 2011</xref>, <xref ref-type="bibr" rid="cms.REF.ganetzky.2015.2411">Ganetzky et al 2015</xref>, <xref ref-type="bibr" rid="cms.REF.tansindhunata.2015.1151">Tan-Sindhunata et al 2015</xref>].</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="cdg" document-type="chapter"><bold>Congenital disorders of glycosylation</bold></related-object>
<bold>(CDG)</bold> are a genetically heterogeneous etiology for individuals with complex neurogenetic malformations and dysmorphic features. Pathogenic variants in <italic toggle="yes">DPAGT1</italic> and <italic toggle="yes">ALG2</italic> have also been shown to be causative for autosomal recessive CDG (DPAGT1-CDG [<italic toggle="yes">CDG-Ij</italic>] and ALG2-CDG [<italic toggle="yes">CDG-Ii</italic>]). The phenotype of individuals with DPAGT1-CDG may show some clinical overlap especially in most severe/prenatal CMS [<xref ref-type="bibr" rid="cms.REF.ganetzky.2015.2411">Ganetzky et al 2015</xref>].</p>
        <p>Pathogenic variants in <italic toggle="yes">GMPPB</italic>, another CMS-related gene of the glycosylation pathway, have also been reported to lead to the phenotype of muscular dystrophy-dystroglycanopathy.</p>
        <p><bold>Pierson syndrome</bold> is mainly characterized by congenital nephrotic syndrome, diffuse mesangial sclerosis, and distinct ocular abnormalities including microcoria. Most affected children exhibit early onset of chronic renal failure, neurodevelopmental deficits, and blindness. It is a rare autosomal recessive disorder caused by pathogenic variants in <italic toggle="yes">LAMB2</italic>. CMS associated with <italic toggle="yes">LAMB2</italic> pathogenic variants has to date been documented exclusively in a patient with additional renal symptoms [<xref ref-type="bibr" rid="cms.REF.maselli.2009.203">Maselli et al 2009</xref>].</p>
      </sec>
      <sec id="cms.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Myasthenia gravis</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/254200">254200</ext-link>). The clinical picture of congenital myasthenic syndromes (CMS) is similar to that of myasthenia gravis (MG), in which individuals have a history of fatigable weakness involving ocular, bulbar, and limb muscles; however, the myasthenic symptoms of CMS usually start at or shortly after birth rather than in adulthood, as is usual for MG. Because seronegative autoimmune MG has been reported on occasion in children younger than age two years, MG may be difficult to differentiate from CMS, especially in later childhood or adulthood. Furthermore, immunosuppressive therapy does not improve clinical symptoms in CMS, whereas it does in MG.</p>
        <p><bold>Transient neonatal myasthenia gravis.</bold> Autoimmune MG can be passed across the placenta from mother to fetus and so can affect offspring at birth.</p>
        <p><bold>Childhood.</bold> Other disorders partially resembling CMS to consider:</p>
        <list list-type="bullet">
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="sma" document-type="chapter">Spinal muscular atrophy</related-object>
            </p>
          </list-item>
          <list-item>
            <p>Spinal muscular atrophy with respiratory distress 1 (SMARD1) (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/604320">604320</ext-link>)</p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="cmd-overview" document-type="chapter">Congenital muscular dystrophies</related-object>
            </p>
          </list-item>
          <list-item>
            <p>Congenital myopathies including <related-object link-type="booklink" source-id="gene" document-id="mtm" document-type="chapter">X-linked myotubular myopathy</related-object>, <related-object link-type="booklink" source-id="gene" document-id="nem" document-type="chapter">nemaline myopathy</related-object>, and <related-object link-type="booklink" source-id="gene" document-id="mmd" document-type="chapter">multiminicore myopathy</related-object></p>
          </list-item>
          <list-item>
            <p>Infantile <related-object link-type="booklink" source-id="gene" document-id="myotonic-d" document-type="chapter">myotonic dystrophy type 1</related-object></p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial myopathies</related-object>
            </p>
          </list-item>
          <list-item>
            <p>Brain stem anomalies</p>
          </list-item>
          <list-item>
            <p>Mobius syndrome (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/157900">157900</ext-link>)</p>
          </list-item>
          <list-item>
            <p>Infantile botulism</p>
          </list-item>
        </list>
        <p><bold>Adulthood.</bold> Other disorders partially resembling CMS to consider:</p>
        <list list-type="bullet">
          <list-item>
            <p>Motor neuron disease including <related-object link-type="booklink" source-id="gene" document-id="kennedy" document-type="chapter">spinal and bulbar muscular atrophy</related-object> (SBMA, Kennedy disease)</p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="lgmd-overview" document-type="chapter">Limb girdle muscular dystrophy</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="fsh" document-type="chapter">Facioscapulohumeral dystrophy</related-object>
            </p>
          </list-item>
          <list-item>
            <p>Mitochondrial myopathy and chronic progressive external ophthalmoplegia (CPEO) (see <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object>)</p>
          </list-item>
          <list-item>
            <p>Autosomal dominant progressive external ophthalmoplegia (ADPEO); caused by pathogenic variants in <italic toggle="yes">SLC25A4</italic> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/609283">609283</ext-link>)<italic toggle="yes">,</italic>
<italic toggle="yes">TWNK</italic> (<italic toggle="yes">C10orf2</italic>) (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/609286">609286</ext-link>)<italic toggle="yes">,</italic> or <related-object link-type="booklink" source-id="gene" document-id="alpers" document-type="chapter"><italic toggle="yes">POLG</italic></related-object></p>
          </list-item>
        </list>
      </sec>
      <sec id="cms.Management">
        <title>Management</title>
        <sec id="cms.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with congenital myasthenic syndromes (CMS), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic/neuropediatric examination. Assessment of strength and motor function; in children, assessment of motor, speech, and cognitive development</p>
            </list-item>
            <list-item>
              <p>Respiratory care. Assessment of respiratory function with baseline pulmonary function tests including forced vital capacity in sitting and supine positions and blood gas exchange. Polysomnography to identify individuals with nocturnal hypoventilation. Symptoms of hypercapnea that should be discussed: daytime headache, restless sleep, loss of concentration, snoring, recurrent respiratory infections, and weight loss. Respiratory studies may be normal between episodes in patients who experience acute crises.</p>
            </list-item>
            <list-item>
              <p>Assessment of contractures and joint deformities by physiatrists and orthopedists; radiologic examinations if spinal deformity is observed</p>
            </list-item>
            <list-item>
              <p>Speech therapy evaluation if dysarthria and/or hypernasal speech is present</p>
            </list-item>
            <list-item>
              <p>For early-onset forms, assessment of feeding abilities (sucking, swallowing, gastroesophageal reflux) and growth parameters to determine the need for feeding interventions such as gavage feeding or gastrostomy insertion</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="cms.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>There are no recent published consensus guidelines for the management of CMS treatment.</p>
          <sec id="cms.Medical_Treatment">
            <title>Medical Treatment</title>
            <p>The choice of medical treatment varies with the CMS subtype [<xref ref-type="bibr" rid="cms.REF.schara.2012.184">Schara et al 2012</xref>, <xref ref-type="bibr" rid="cms.REF.finlayson.2013.80">Finlayson et al 2013</xref>]. Therefore, it seems reasonable to consider a first-line genetic testing to evaluate the genetic subtype. However, there may be individual clinical situations demanding an immediate therapeutic trial. Monotherapy is the usual course of treatment for congenital myasthenia; however, a combination of drugs may be necessary to optimize the therapeutic effect and to minimize side effects.</p>
            <p><bold>Acetylcholineesterase (AChE) inhibitors (pyridostigmine).</bold> Although the majority of individuals with CMS benefit from AChE inhibitors (pyridostigmine), some myasthenic symptoms may remain refractory to treatment even in individuals who are otherwise responsive. Certain CMS subtypes (see <xref ref-type="table" rid="cms.T.cms_subtypes_by_gene_involved">Table 2</xref>) including endplate (EP) AChE deficiency, slow-channel CMS (SCCMS), and <italic toggle="yes">DOK7</italic>-related CMS are refractory to or deteriorate with AChE inhibitors [<xref ref-type="bibr" rid="cms.REF.schara.2012.184">Schara et al 2012</xref>, <xref ref-type="bibr" rid="cms.REF.finlayson.2013.80">Finlayson et al 2013</xref>].</p>
            <p><bold>3,4-diaminopyridine (3,4-DAP).</bold> Alternatively or in addition to AChE inhibitors, the potassium channel blocker 3,4-DAP may be used [<xref ref-type="bibr" rid="cms.REF.schara.2012.184">Schara et al 2012</xref>, <xref ref-type="bibr" rid="cms.REF.finlayson.2013.80">Finlayson et al 2013</xref>]. This drug increases the release of ACh and prolongs the presynaptic action potential. Of note, two children with fast-channel CMS (FCCMS; caused by autosomal recessive loss-of-function variants of the genes encoding the acetylcholine receptor (AChR) subunits that shorten the time that the AChR channel is open) died when started on 3,4-DAP [<xref ref-type="bibr" rid="cms.REF.beeson.2005.498">Beeson et al 2005</xref>]. Although a relation to 3,4-DAP has not been proven, clinicians must be cautious when using 3,4-DAP in young children and in individuals with FCCMS.</p>
            <p><bold>Ephedrine</bold> treatment shows positive effects in different subtypes of CMS [<xref ref-type="bibr" rid="cms.REF.schara.2012.184">Schara et al 2012</xref>, <xref ref-type="bibr" rid="cms.REF.finlayson.2013.80">Finlayson et al 2013</xref>, <xref ref-type="bibr" rid="cms.REF.vrinten.2014.cd010028">Vrinten et al 2014</xref>] and may be an alternative treatment option for CMS subtypes that are refractory to AChE inhibitors, such as <italic toggle="yes">COLQ-</italic> and <italic toggle="yes">DOK7</italic>-associated CMS [<xref ref-type="bibr" rid="cms.REF.bestuecardiel.2005.144">Bestue-Cardiel et al 2005</xref>, <xref ref-type="bibr" rid="cms.REF.schara.2009.828">Schara et al 2009</xref>, <xref ref-type="bibr" rid="cms.REF.lashley.2010.1517">Lashley et al 2010</xref>, <xref ref-type="bibr" rid="cms.REF.witting.2014.350">Witting &#x00026; Vissing 2014</xref>]. It is well tolerated by most patients and improvement in strength can be profound.</p>
            <p><bold>Albuterol,</bold> an alternative to ephedrine, may have a role in the treatment of <italic toggle="yes">COLQ-</italic> and <italic toggle="yes">DOK7</italic>-associated CMS [<xref ref-type="bibr" rid="cms.REF.liewluck.2011.789">Liewluck et al 2011</xref>, <xref ref-type="bibr" rid="cms.REF.burke.2013.170">Burke et al 2013</xref>, <xref ref-type="bibr" rid="cms.REF.lorenzoni.2013.155">Lorenzoni et al 2013</xref>, <xref ref-type="bibr" rid="cms.REF.witting.2014.350">Witting &#x00026; Vissing 2014</xref>].</p>
            <p><bold>Quinidine, fluoxetine.</bold> Some individuals with genetically defined SCCMS (caused by autosomal dominant gain-of-function variants of the genes encoding the AChR subunits that prolong the time that the AChR channel is open) have been successfully treated with quinidine, a long-lived open-channel blocker of AChR [<xref ref-type="bibr" rid="cms.REF.harper.1998.480">Harper &#x00026; Engel 1998</xref>]. Quinidine in turn may be detrimental in individuals with AChR deficiency.</p>
            <p>The therapeutic benefit of fluoxetine in SCCMS has been shown [<xref ref-type="bibr" rid="cms.REF.harper.2003.1710">Harper et al 2003</xref>, <xref ref-type="bibr" rid="cms.REF.colomer.2006.329">Colomer et al 2006</xref>]; however, it may induce suicidal ideation; thus, caution is strongly suggested in its use in childhood [<xref ref-type="bibr" rid="cms.REF.engel.2007.252">Engel 2007</xref>].</p>
            <p>Overall fluoxetine appears to be the accepted first-line treatment in SCCMS, whereas quinidine is the treatment of choice in children and teenagers because of the risk of psychiatric side effects associated with fluoxetine [<xref ref-type="bibr" rid="cms.REF.chaouch.2012a.566">Chaouch et al 2012a</xref>, <xref ref-type="bibr" rid="cms.REF.chaouch.2012b.474">Chaouch et al 2012b</xref>].</p>
          </sec>
          <sec id="cms.NonMedical_Treatment">
            <title>Non-Medical Treatment</title>
            <p>In addition to medical therapy, a multidisciplinary approach to the clinical management of the affected individual greatly improves quality of life and can influence survival. Management should be tailored to each individual, their specific CMS subtype, and rate of progression.</p>
            <p>Depending on the individual clinical situation the clinical management may include the following:</p>
            <list list-type="bullet">
              <list-item>
                <p>Physical and occupational therapy</p>
              </list-item>
              <list-item>
                <p>Speech therapy</p>
              </list-item>
              <list-item>
                <p>Orthotics or a wheelchair</p>
              </list-item>
              <list-item>
                <p>A percutaneous gastric tube</p>
              </list-item>
              <list-item>
                <p>Ventilatory support</p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="cms.Prevention_of_Primary_Manifestations">
          <title>Prevention of Primary Manifestations</title>
          <p>Sudden respiratory insufficiency or apneic attacks provoked by fever or infections are common in individuals with pathogenic variants in <italic toggle="yes">CHAT</italic> or <italic toggle="yes">RAPSN</italic>, even if the myasthenic symptoms are mild between crises. These individuals should receive prophylactic anticholinesterase therapy. Note: Less frequently, acute respiratory events may also occur in other CMS subtypes. Parents of infants are advised to use apnea monitors and be trained in CPR.</p>
        </sec>
        <sec id="cms.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Side effects of drugs used to treat myasthenic symptoms should be carefully monitored. If necessary, individual doses should be adjusted or treatment should be stopped. For example, quinidine has some major side effects including <italic toggle="yes">torsades de pointes</italic> (a potentially life-threatening arrhythmia), hypotension, cinchonism (or quininism), and hypersensitivity reactions. In individuals with CMS, adverse effects including exacerbation of weakness and development of respiratory failure may occur.</p>
        </sec>
        <sec id="cms.Surveillance">
          <title>Surveillance</title>
          <p>Routine surveillance of muscle strength and respiratory function is recommended. In some patients, especially those with <italic toggle="yes">COLQ</italic> and <italic toggle="yes">DOK7</italic> pathogenic variants, slowly progressive respiratory impairment is seen with increasing age. Symptoms of nighttime hypoventilation should be considered.</p>
        </sec>
        <sec id="cms.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>A number of drugs are known to affect neuromuscular transmission and therefore exacerbate symptoms of myasthenia gravis (e.g., ciprofloxacin, chloroquine, procaine, lithium, phenytoin, beta-blockers, procainamide, and quinidine). These drugs are not absolutely contraindicated and may be used with caution in CMS. See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.myasthenia.org/LinkClick.aspx?fileticket=JuFvZPPq2vg%3d&#x00026;tabid=82">Medications and Myasthenia Gravis</ext-link> (Table 2) for a more complete.</p>
        </sec>
        <sec id="cms.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate apparently asymptomatic at-risk relatives of a proband in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures, especially newborns or young children, who could benefit from early treatment to prevent sudden respiratory failure.</p>
          <p>Evaluations can include:</p>
          <list list-type="bullet">
            <list-item>
              <p>Molecular genetic testing if the pathogenic variant in the family is known;</p>
            </list-item>
            <list-item>
              <p>Neurologic/neuropediatric examination, electrophysiologic testing (repetitive nerve stimulation) if the pathogenic variant in the family is not known.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="cms.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="cms.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Data on pregnancies in CMS are limited. Seventeen pregnancies were reported in eight French patients with CMS [<xref ref-type="bibr" rid="cms.REF.servais.2013.815">Servais et al 2013</xref>]. According to these data pregnancy was a frequent cause of clinical exacerbation but the vast majority of patients recovered their pre-pregnancy clinical status six months after delivery. The children&#x02019;s outcome was excellent, except for one newborn who developed a severe, neonatal (autosomal dominant) slow-channel CMS. Pregnant patients should be closely followed by neurologists during the course of pregnancy. Careful respiratory and cardiac surveillance should be initiated in consultation with obstetric specialists.</p>
        </sec>
        <sec id="cms.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="cms.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="cms.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Congenital myasthenic syndrome (CMS) caused by mutation of <italic toggle="yes">AGRN</italic>, <italic toggle="yes">ALG14</italic>, <italic toggle="yes">ALG2</italic>, <italic toggle="yes">CHAT</italic>, <italic toggle="yes">COL13A1</italic>, <italic toggle="yes">COLQ</italic>, <italic toggle="yes">DOK7</italic>, <italic toggle="yes">DPAGT1</italic>, <italic toggle="yes">GFPT1</italic>, <italic toggle="yes">GMPPB</italic>, <italic toggle="yes">LAMB2,</italic>
<italic toggle="yes">LRP4</italic>, <italic toggle="yes">MUSK</italic>, <italic toggle="yes">MYO9A</italic>, <italic toggle="yes">PLEC</italic>, <italic toggle="yes">PREPL</italic>, <italic toggle="yes">RAPSN</italic>, <italic toggle="yes">SCN4A</italic>, and <italic toggle="yes">SLC25A1</italic> is always inherited in an autosomal recessive manner.</p>
          <p>CMS caused by mutation of <italic toggle="yes">SYT2</italic> and <italic toggle="yes">SLC5A7</italic> is inherited in autosomal dominant manner.</p>
          <p><italic toggle="yes">SNAP25-</italic>related CMS has been described as the result of an autosomal dominant <italic toggle="yes">de novo</italic> pathogenic variant.</p>
          <p>CMS associated with pathogenic variants in the genes encoding the AChR subunits (<italic toggle="yes">CHRNA1</italic>, <italic toggle="yes">CHRNB1</italic>, <italic toggle="yes">CHRND</italic>, and <italic toggle="yes">CHRNE</italic>) can be inherited in an autosomal dominant or autosomal recessive manner.</p>
          <list list-type="bullet">
            <list-item>
              <p>Gain-of-function variants in <italic toggle="yes">CHRNA1</italic>, <italic toggle="yes">CHRNB1</italic>, <italic toggle="yes">CHRND</italic>, and <italic toggle="yes">CHRNE</italic> that alter the kinetic properties of the AChR result in autosomal dominant slow-channel CMS.</p>
            </list-item>
            <list-item>
              <p>Loss-of-function variants in the AChR subunit genes (<italic toggle="yes">CHRNA1</italic>, <italic toggle="yes">CHRNB1</italic>, <italic toggle="yes">CHRND</italic>, and <italic toggle="yes">CHRNE</italic>) are associated with autosomal recessive CMS [<xref ref-type="bibr" rid="cms.REF.hanta_.2004.539">Hanta&#x000ef; et al 2004</xref>, <xref ref-type="bibr" rid="cms.REF.ohno.2004a.117">Ohno &#x00026; Engel 2004a</xref>, <xref ref-type="bibr" rid="cms.REF.engel.2005.308">Engel &#x00026; Sine 2005</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="cms.Risk_to_Family_Members__Autosomal_Re">
          <title>Risk to Family Members &#x02014; Autosomal Recessive Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of a child with an autosomal recessive congenital myasthenic syndrome (AR-CMS) are obligate heterozygotes (i.e., carriers of one pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are clinically asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are clinically asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The offspring of an individual with AR-CMS are obligate heterozygotes (carriers) for a pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>The risk that the offspring will inherit a second CMS-related pathogenic variant depends on the carrier status of the proband's reproductive partner.</p>
            </list-item>
            <list-item>
              <p>The carrier frequency of CMS-related pathogenic variants in the general population is low.</p>
            </list-item>
            <list-item>
              <p>In populations with a high carrier rate and/or a high rate of consanguineous marriages, the risk to the offspring of an affected individual of being affected is increased (see <xref ref-type="sec" rid="cms.Prevalence">Prevalence</xref>).</p>
            </list-item>
          </list>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier of a CMS-related pathogenic variant.</p>
          <p>
            <bold>Carrier (Heterozygote) Detection</bold>
          </p>
          <p>Carrier testing for at-risk relatives requires prior identification of the CMS-related pathogenic variants in the family.</p>
        </sec>
        <sec id="cms.Risk_to_Family_Members__Autosomal_Do">
          <title>Risk to Family Members &#x02014; Autosomal Dominant Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Some individuals diagnosed with an autosomal dominant congenital myasthenic syndrome (AD-CMS) have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with an AD-CMS may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by a <italic toggle="yes">de novo</italic> pathogenic variant is unknown.</p>
            </list-item>
            <list-item>
              <p>Molecular genetic testing is recommended for the parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, two possible explanations are a <italic toggle="yes">de novo</italic> pathogenic variant in the proband or germline mosaicism in a parent.</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband.</bold> The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents:</p>
          <list list-type="bullet">
            <list-item>
              <p>If a parent of the proband is affected and/or has a pathogenic variant, the risk of inheriting the variant is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected and the pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to the sibs of a proband is low but greater than in the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with AD-CMS has a 50% chance of inheriting the pathogenic variant.</p>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the status of the proband's parents: if a parent is affected and/or has a CMS-related pathogenic variant, his or her family members are at risk.</p>
        </sec>
        <sec id="cms.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="cms.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo</italic> pathogenic variant. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="cms.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the CMS-related pathogenic variant(s) have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for CMS are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="cms.Resources">
        <title>Resources</title>
      </sec>
      <sec id="cms.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="cms.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>The understanding of the molecular basis of the different subtypes of CMS has been evolving since 1995. After the identification of pathogenic variants in the subunits of the nicotinic acetylcholine receptor (AChR), other genes encoding postsynaptic, presynaptic, or synaptic proteins were identified as candidate genes for CMS [<xref ref-type="bibr" rid="cms.REF.engel.2003.339">Engel et al 2003</xref>, <xref ref-type="bibr" rid="cms.REF.hanta_.2004.539">Hanta&#x000ef; et al 2004</xref>, <xref ref-type="bibr" rid="cms.REF.ohno.2004a.117">Ohno &#x00026; Engel 2004a</xref>, <xref ref-type="bibr" rid="cms.REF.beeson.2005.498">Beeson et al 2005</xref>, <xref ref-type="bibr" rid="cms.REF.engel.2005.308">Engel &#x00026; Sine 2005</xref>, <xref ref-type="bibr" rid="cms.REF.m_ller.2007b.1">M&#x000fc;ller et al 2007b</xref>]. Currently, several proteins expressed at the neuromuscular junction and involved in neuromuscular transmission have been found to be involved in CMS. CMS subtypes have been classified according to the site of the underlying defect into presynaptic, synaptic, and postsynaptic CMS. This classification is still tentative because it is likely that additional subtypes of CMS will be discovered.</p>
          <p><bold>The neuromuscular junction (NMJ).</bold> Neuromuscular transmission depends on the calcium-dependent release of acetylcholine (ACh) from the presynaptic nerve terminal and its interaction with AChRs on the postsynaptic membrane. ACh is first synthesized in the motor nerve terminal by the action of the enzyme choline acetyltransferase (ChAT), and is transported into the synaptic vesicles via a specific uptake mechanism. Following depolarization of the motor nerve terminal by the axonal action potential, calcium influx via voltage-gated calcium channels triggers events that lead to vesicle fusion and release of acetylcholine. Binding of ACh to AChR leads to the opening of the AChR ion channel resulting in depolarization of the postsynaptic membrane. If this depolarization exceeds that required to open the voltage-gated sodium channels on the postsynaptic side, an action potential is generated and propagated throughout the muscle fiber, leading to contraction of the muscle. ACh is hydrolyzed by the enzyme acetylcholinesterase (AChE), which is localized at the basal lamina of the NMJ, and the membrane potential of the presynaptic membrane is restored when voltage-gated potassium channels open.</p>
          <p><bold>The majority of postsynaptic CMS subtypes</bold> involve mutation of the genes <italic toggle="yes">CHRNA1</italic>, <italic toggle="yes">CHRNB1</italic>, <italic toggle="yes">CHRND</italic>, and <italic toggle="yes">CHRNE</italic> encoding, respectively, the five homologous subunits of the adult AChR: two &#x003b1; subunits, and one each of &#x003b2;, &#x003b4;, and &#x003b5;. Mutation of these genes either increases or decreases the response to acetylcholine. After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to the opening of an ion-conducting channel. Each of the homologous subunits has a large N-terminal extracellular domain, four transmembrane segments (M1-M4) with the M2 domain lining the cation-selective pore. Each AChR has two acetylcholine binding pockets, one at the &#x003b1;/&#x003b5; interface and one at the &#x003b1;/&#x003b4; interface.</p>
          <p>CMS with kinetic abnormalities of the acetylcholine receptor (slow-channel syndromes and fast-channel syndromes) is caused by pathogenic variants in the acetylcholine receptor subunit genes <italic toggle="yes">CHRNA1</italic>, <italic toggle="yes">CHRNB1</italic>, <italic toggle="yes">CHRND</italic>, and <italic toggle="yes">CHRNE</italic>. Two major kinetic abnormalities of AChR, resulting in slow-channel syndromes and fast-channel syndromes, have emerged. The two kinetic syndromes are physiologic and morphologic opposites and call for different therapeutic modalities.</p>
          <p>The AChR subunits in individuals with CMS have numerous homozygous or, more frequently, compound heterozygous pathogenic variants that result in a reduced number of functional AChRs at the postsynaptic membrane. Although these low-expressor or null variants have been reported in all the genes encoding subunits of the adult AChR (i.e., <italic toggle="yes">CHRNA1</italic>, <italic toggle="yes">CHRNB1</italic>, <italic toggle="yes">CHRND</italic>, and <italic toggle="yes">CHRNE)</italic>, they are concentrated in <italic toggle="yes">CHRNE</italic> (encoding the &#x003b5; subunit), especially in its long cytoplasmic M3/M4 linker. Click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="cms-AChR_subunit.pdf" content-type="local-data">here</inline-supplementary-material> for more information on the AChR subunit genes.</p>
          <sec id="cms.CHAT">
            <title>
              <italic toggle="yes">CHAT</italic>
            </title>
            <p><bold>Gene structure.</bold> A presynaptic subtype of CMS has been linked to pathogenic variants in <italic toggle="yes">CHAT</italic>, the gene encoding choline O-acetyltransferase (ChAT) [<xref ref-type="bibr" rid="cms.REF.ohno.2001.2017">Ohno et al 2001</xref>]. <italic toggle="yes">CHAT</italic> comprises 18 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cms" object-id="cms.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Loss-of-function variants (pathogenic missense, frameshift, and stop variants) causing autosomal recessive CMS have been identified in more than 40 kinships with CMS clinically characterized as CMS-EA (episodic apnea) [<xref ref-type="bibr" rid="cms.REF.chaouch.2012a.566">Chaouch et al 2012a</xref>].</p>
            <table-wrap id="cms.T.selected_chat_pathogenic_variants" orientation="portrait" position="anchor">
              <label>Table 3. </label>
              <caption>
                <p>Selected <italic toggle="yes">CHAT</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_cms.T.selected_chat_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_cms.T.selected_chat_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_cms.T.selected_chat_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_cms.T.selected_chat_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.914T&#x0003e;C</td>
                    <td headers="hd_h_cms.T.selected_chat_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ile305Thr</td>
                    <td headers="hd_h_cms.T.selected_chat_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_020549.4">NM_020549.4</ext-link>
<break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_065574.3">NP_065574.3</ext-link></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> ChAT catalyzes the reversible synthesis of acetylcholine from acetyl-coenzyme A and choline.</p>
            <p><bold>Abnormal gene product.</bold> Biochemical studies have established reduced catalytic efficiency and/or reduced expression of mutated gene products.</p>
          </sec>
          <sec id="cms.CHRNE">
            <title>
              <italic toggle="yes">CHRNE</italic>
            </title>
            <p><bold>Gene structure.</bold> The <italic toggle="yes">CHRNE</italic> reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000080.3">NM_000080.3</ext-link> comprises 12 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cms" object-id="cms.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> To date, more than 50 &#x003b5; subunit pathogenic variants have been reported [<xref ref-type="bibr" rid="cms.REF.ohno.2004a.117">Ohno &#x00026; Engel 2004a</xref>, <xref ref-type="bibr" rid="cms.REF.engel.2005.308">Engel &#x00026; Sine 2005</xref>].</p>
            <list list-type="bullet">
              <list-item>
                <p>Most such pathogenic variants are nonsense, splice site, or frameshift variants resulting in a premature termination of the translational chain.</p>
              </list-item>
              <list-item>
                <p>Missense variants alter residues essential for assembly (e.g., glycosylation sites, the cystine loop) or in the signal peptide, also resulting in reduced gene expression. Some missense variants affecting AChR gene expression also have accompanying kinetic effects.</p>
              </list-item>
              <list-item>
                <p>Single-nucleotide variants of a regulatory element (N-box) in the AChR&#x003b5; promoter region have been shown to result in reduced gene expression [<xref ref-type="bibr" rid="cms.REF.nichols.1999.439">Nichols et al 1999</xref>, <xref ref-type="bibr" rid="cms.REF.ohno.1999.131">Ohno et al 1999</xref>, <xref ref-type="bibr" rid="cms.REF.abicht.2002.1005">Abicht et al 2002</xref>].</p>
              </list-item>
              <list-item>
                <p>A chromosomal microdeletion of 1290 bp encompassing parts of <italic toggle="yes">CHRNE</italic> has been shown to result in CMS [<xref ref-type="bibr" rid="cms.REF.abicht.2002.1005">Abicht et al 2002</xref>].</p>
              </list-item>
            </list>
            <p>One particular single-nucleotide variant in the AChR&#x003b5; subunit (c.1327delG) resulting in endplate AChR deficiency has been shown to be common (~50%) in affected individuals of Romany and/or southeastern European ethnic origin [<xref ref-type="bibr" rid="cms.REF.abicht.1999.1564">Abicht et al 1999</xref>, <xref ref-type="bibr" rid="cms.REF.karcagi.2001.231">Karcagi et al 2001</xref>, <xref ref-type="bibr" rid="cms.REF.morar.2004.596">Morar et al 2004</xref>].</p>
            <p>Another pathogenic variant in the AChR&#x003b5; subunit (c.1353dupG) is frequent in the Maghreb (especially Algeria and Tunisia), likely because of an ancient founder effect [<xref ref-type="bibr" rid="cms.REF.beeson.2005.498">Beeson et al 2005</xref>].</p>
            <table-wrap id="cms.T.selected_chrne_pathogenic_variants" orientation="portrait" position="anchor">
              <label>Table 4. </label>
              <caption>
                <p>Selected <italic toggle="yes">CHRNE</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene</th>
                    <th id="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change <break/>(Alias&#x000a0;<sup>1</sup>)</th>
                    <th id="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_1" rowspan="4" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">CHRNE</italic>
                    </td>
                    <td headers="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.130dupG</td>
                    <td headers="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Glu44GlyfsTer3</td>
                    <td headers="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_4" rowspan="4" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000080.3">NM_000080.3</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000071.1">NP_000071.1</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1327delG<break/>(&#x003b5;1267delG)</td>
                    <td headers="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Glu443LysfsTer64</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1353dupG<break/>(&#x003b5;1293insG)</td>
                    <td headers="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Asn452GlufsTer4</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">(del1290)&#x000a0;<sup>2</sup></td>
                    <td headers="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Null</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="cms.TF.4.1">
                  <label>1. </label>
                  <p>Variant designation that does not conform to current naming conventions</p>
                </fn>
                <fn id="cms.TF.4.2">
                  <label>2. </label>
                  <p>1290-bp deletion from the promoter to exon 2 [<xref ref-type="bibr" rid="cms.REF.abicht.2002.1005">Abicht et al 2002</xref>]</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">CHRNE</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000071.1">NP_000071.1</ext-link>) comprises 493 amino acids.</p>
            <p><bold>Abnormal gene product.</bold> Morphologic studies of endplates show an increased number of endplate regions distributed over an increased span of the muscle fiber. The integrity of the junctional folds is preserved, but AChR expression on the folds is patchy and faint. The fetal type &#x003b3; subunit may partially compensate for absence of the &#x003b5; subunit, thereby producing a less severe phenotype.</p>
          </sec>
          <sec id="cms.COLQ">
            <title>
              <italic toggle="yes">COLQ</italic>
            </title>
            <p><bold>Gene structure.</bold> A synaptic subtype of CMS has been linked to pathogenic variants in <italic toggle="yes">COLQ</italic>, the gene encoding the collagenic tail ColQ. <italic toggle="yes">COLQ</italic> comprises 17 exons (and 2 alternate exons: 1A and 11A).</p>
            <p><bold>Pathogenic variants.</bold> All individuals with endplate (EP) AChE deficiency described to date have pathogenic variants in <italic toggle="yes">COLQ</italic>. To date, pathogenic variants (missense, frameshift, stop, and splice site variants) causing autosomal recessive CMS have been identified in more than 100 CMS kinships [<xref ref-type="bibr" rid="cms.REF.chaouch.2012a.566">Chaouch et al 2012a</xref>].</p>
            <p><bold>Normal gene product.</bold> The endplate species of AChE is a heteromeric asymmetric enzyme composed of one, two, or three homotetramers of globular catalytic subunits (AChE<sub>T</sub>) attached to a triple-stranded collagenic tail (ColQ) anchoring the enzyme to the synaptic basal lamina. ColQ has an N-terminal proline-rich region attachment domain (PRAD), a collagenic central domain, and a C-terminal region enriched in charged residues and cysteines. Each ColQ strand can bind an AChE<sub>T</sub> tetramer to its PRAD, giving rise to A<sub>4</sub>, A<sub>8</sub>, and A<sub>12</sub> species of asymmetric AChE. Two groups of charged residues in the collagen domain (heparan sulfate proteoglycan binding domains [HSPBD]) plus other residues in the C-terminal region assure that the asymmetric enzyme is inserted into the synaptic basal lamina. The C-terminal region is also required for initiating the triple helical assembly of ColQ that proceeds from a C- to an N-terminal direction in a zipper-like manner.</p>
            <p><bold>Abnormal gene product.</bold> The <italic toggle="yes">COLQ</italic>-associated synaptic subtype of CMS is caused by the absence of acetylcholinesterase (AChE) from the synaptic cleft as a result of pathogenic variants in the triple-stranded collagenic tail (ColQ) anchoring the enzyme to the synaptic basal lamina [<xref ref-type="bibr" rid="cms.REF.donger.1998.967">Donger et al 1998</xref>, <xref ref-type="bibr" rid="cms.REF.ohno.1998.9654">Ohno et al 1998</xref>, <xref ref-type="bibr" rid="cms.REF.ohno.2000.162">Ohno et al 2000</xref>].</p>
            <p>Biochemical studies have established three major functional consequences resulting from pathogenic variants:</p>
            <list list-type="bullet">
              <list-item>
                <p>Pathogenic variants in the PRAD-domain prevent attachment of AChE<sub>T</sub> to ColQ;</p>
              </list-item>
              <list-item>
                <p>Pathogenic variants in the collagen-domain produce a short, single-stranded ColQ that binds a single AChE<sub>T</sub> tetramer and is insertion incompetent;</p>
              </list-item>
              <list-item>
                <p>Pathogenic variants in the C-terminus hinder the triple helical assembly of the collagen domain, or produce an asymmetric species of AChE that is insertion incompetent, or both.</p>
              </list-item>
            </list>
            <p>Neuromuscular transmission in absence of AChE is compromised by a desensitization and depolarization block of AChR at physiologic rates of stimulation, an endplate myopathy caused by cholinergic overactivity with a likely compensatory smallness of the nerve terminals and their encasement by Schwann cells. Endplate potentials and currents are prolonged in the absence of AChE, eliciting repetitive compound muscle action potentials.</p>
          </sec>
          <sec id="cms.DOK7">
            <title>
              <italic toggle="yes">DOK7</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">DOK7</italic>, encoding the postsynaptic protein Dok-7, comprises seven exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cms" object-id="cms.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold>
<italic toggle="yes">DOK7</italic> pathogenic variants were recently identified in individuals with congenital myasthenic syndromes affecting primarily the proximal limb muscles (&#x02018;limb girdle myasthenia&#x02019;) [<xref ref-type="bibr" rid="cms.REF.beeson.2006.1975">Beeson et al 2006</xref>, <xref ref-type="bibr" rid="cms.REF.m_ller.2007a.1497">M&#x000fc;ller et al 2007a</xref>, <xref ref-type="bibr" rid="cms.REF.palace.2007.1507">Palace et al 2007</xref>]. Since then, a large number of autosomal recessive pathogenic variants have been reported in more than 150 kinships [<xref ref-type="bibr" rid="cms.REF.chaouch.2012a.566">Chaouch et al 2012a</xref>]. Most affected individuals have the C-terminal frameshift c.1124_1127dupTGCC on at least one allele.</p>
            <table-wrap id="cms.T.selected_dok7_pathogenic_variants" orientation="portrait" position="anchor">
              <label>Table 5. </label>
              <caption>
                <p>Selected <italic toggle="yes">DOK7</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_cms.T.selected_dok7_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_cms.T.selected_dok7_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_cms.T.selected_dok7_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_cms.T.selected_dok7_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1124_1127dupTGCC</td>
                    <td headers="hd_h_cms.T.selected_dok7_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala378SerfsTer30</td>
                    <td headers="hd_h_cms.T.selected_dok7_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_173660.4">NM_173660.4</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_775931.3">NP_775931.3</ext-link>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> Dok (&#x0201c;downstream of kinase&#x0201d;) -7 is a 43-kd MuSK-interacting postsynaptic protein [<xref ref-type="bibr" rid="cms.REF.okada.2006.1802">Okada et al 2006</xref>] that is essential for synaptogenesis. Previously known Dok-family proteins (Dok-1 to Dok-6) play a role in signaling downstream of receptor and non-receptor phosphotyrosine kinases. Like other Dok proteins, Dok-7 has a pleckstrin-homology (PH) domain and a phosphotyrosine-binding (PTB) domain in the N-terminal moiety and multiple tyrosine residues in the C-terminal region.</p>
            <p><xref ref-type="bibr" rid="cms.REF.okada.2006.1802">Okada et al [2006]</xref> demonstrated that Dok-7 overexpression can induce the aneural activation of MuSK and subsequent clustering of AChR in cultured myotubes. Unique among adaptor proteins recruited to receptor tyrosine kinases, Dok7 is not only a substrate of MuSK, but also an activator of MuSK&#x02019;s kinase activity.</p>
            <p>The crystal structure of the Dok7 PH-PTB domains in complex with a phosphopeptide representing the Dok7-binding site on MuSK revealed a dimeric arrangement of Dok7 PH-PTB that facilitates transautophosphorylation of the kinase activation loop [<xref ref-type="bibr" rid="cms.REF.bergamin.2010.100">Bergamin et al 2010</xref>].</p>
            <p><bold>Abnormal gene product.</bold> Analysis of AChR clusters induced by Dok-7 harboring the pathogenic variant c.1124_1127dupTGCC showed a significant reduction in the number of branched-type AChR plaques compared to wild-type Dok-7 in fully differentiated transfected C2C12 myotubes [<xref ref-type="bibr" rid="cms.REF.beeson.2006.1975">Beeson et al 2006</xref>]. By contrast, the ability of the c.1124_1127dupTGCC mutant to bind and induce MuSK phosphorylation was not impaired in non-differentiated myoblasts and in heterologous cells, suggesting that the C-terminal domain could play a key role in the maturation of the synaptic structure. Other pathogenic variants in the C-terminal domain of Dok-7 may have similar effects in myotubes.</p>
          </sec>
          <sec id="cms.GFPT1">
            <title>
              <italic toggle="yes">GFPT1</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">GFPT1</italic> comprises 19 exons, plus one additional alternative exon 8A, which is incorporated only into a longer isoform <italic toggle="yes">GFPT1L</italic>, resulting in the insertion of 18 additional amino acids. <italic toggle="yes">GFPT1L</italic> is mainly expressed in skeletal muscle and heart and is the predominant <italic toggle="yes">GFPT1</italic> species in these tissues [<xref ref-type="bibr" rid="cms.REF.niimi.2001.566">Niimi et al 2001</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cms" object-id="cms.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold>
<italic toggle="yes">GFPT1</italic> pathogenic variants have been identified in more than 20 individuals with a subtype of CMS referred to as congenital myasthenic syndrome with tubular aggregates (CMS-TA) [<xref ref-type="bibr" rid="cms.REF.guergueltcheva.2012.838">Guergueltcheva et al 2012</xref>, <xref ref-type="bibr" rid="cms.REF.senderek.2011.162">Senderek et al 2011</xref>]. Nineteen different <italic toggle="yes">GFPT1</italic> pathogenic variants comprising 13 missense pathogenic variants, four frameshifts, one nonsense variant, and one variant in the 3&#x02019;-UTR were identified. No individual with CMS with two null variants in the constitutive exons resulting in a complete loss of GFPT1 expression has been identified.</p>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">GFPT1</italic> encodes an 80-kd enzyme that is part of the hexosamine biosynthesis pathway. GFPT1 catalyzes the transfer of an amino group from glutamine onto fructose-6-phosphate, yielding glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 and glutamate. This transamidase reaction has been identified as the first and rate-limiting step of the hexosamine biosynthesis pathway. Products of this biochemical pathway are the sugar building blocks for the glycosylation of proteins and lipids in all cells.</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants in <italic toggle="yes">GFPT1</italic> lead to reduced protein levels in muscle; some missense pathogenic variants also slightly reduce the enzymatic activity [<xref ref-type="bibr" rid="cms.REF.senderek.2011.162">Senderek et al 2011</xref>]. The precise mechanism by which GFPT1 deficiency induces a dysfunction of the neuromuscular junction is not yet understood.</p>
          </sec>
          <sec id="cms.RAPSN">
            <title>
              <italic toggle="yes">RAPSN</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">RAPSN</italic>, encoding the postsynaptic protein rapsyn (43-kd receptor-associated protein of the synapse), comprises eight exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cms" object-id="cms.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Nearly 200 pathogenic variants in <italic toggle="yes">RAPSN</italic> have been identified to date in the coding region (missense, frameshift, stop, and splice site variants) and the promoter region [<xref ref-type="bibr" rid="cms.REF.ohno.2004a.117">Ohno &#x00026; Engel 2004a</xref>, <xref ref-type="bibr" rid="cms.REF.engel.2005.308">Engel &#x00026; Sine 2005</xref>, <xref ref-type="bibr" rid="cms.REF.m_ller.2007b.1">M&#x000fc;ller et al 2007b</xref>, <xref ref-type="bibr" rid="cms.REF.milone.2009.228">Milone et al 2009</xref>, <xref ref-type="bibr" rid="cms.REF.chaouch.2012a.566">Chaouch et al 2012a</xref>].</p>
            <list list-type="bullet">
              <list-item>
                <p>The missense variant c.264C&#x0003e;A (p.Asn88Lys) has been identified in many individuals who have pathogenic variants in the coding region in at least one allele. There is evidence for an ancient Indo-European founder [<xref ref-type="bibr" rid="cms.REF.richard.2003.e81">Richard et al 2003</xref>, <xref ref-type="bibr" rid="cms.REF.m_ller.2004a.e104">M&#x000fc;ller et al 2004a</xref>]; however, not all affected individuals with c.264C&#x0003e;A have the same haplotype [<xref ref-type="bibr" rid="cms.REF.richard.2003.e81">Richard et al 2003</xref>, <xref ref-type="bibr" rid="cms.REF.ohno.2004b.e8">Ohno &#x00026; Engel 2004b</xref>].</p>
              </list-item>
              <list-item>
                <p>Other pathogenic variants in the translated region are dispersed over different domains of the protein.</p>
              </list-item>
              <list-item>
                <p>One affected individual was found to be a compound heterozygote with the c.264C&#x0003e;A pathogenic variant and a large (~4.5-kb) deletion disrupting the other allele [<xref ref-type="bibr" rid="cms.REF.m_ller.2004b.744">M&#x000fc;ller et al 2004b</xref>].</p>
              </list-item>
              <list-item>
                <p>Heteroallelic multiexon deletions may be common and present in up to 15% of cases [<xref ref-type="bibr" rid="cms.REF.gaudon.2010.795">Gaudon et al 2010</xref>].</p>
              </list-item>
              <list-item>
                <p>Pathogenic variants in E-box regions of the promoter have been identified (<xref ref-type="table" rid="cms.T.selected_rapsn_pathogenic_variants">Table 6</xref>).</p>
              </list-item>
            </list>
            <table-wrap id="cms.T.selected_rapsn_pathogenic_variants" orientation="portrait" position="anchor">
              <label>Table 6. </label>
              <caption>
                <p>Selected <italic toggle="yes">RAPSN</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_cms.T.selected_rapsn_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change <break/>(Alias)&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_cms.T.selected_rapsn_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_cms.T.selected_rapsn_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_cms.T.selected_rapsn_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.-210A&#x0003e;G&#x000a0;<sup>2,&#x000a0;3</sup><break/>(-38A&#x0003e;G)&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_cms.T.selected_rapsn_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                    <td headers="hd_h_cms.T.selected_rapsn_pathogenic_variants_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_005055.4">NM_005055.4</ext-link>
<break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_005046.2">NP_005046.2</ext-link></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cms.T.selected_rapsn_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.-199C&#x0003e;G&#x000a0;<sup>2,&#x000a0;5</sup><break/>(-27C&#x0003e;G)&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_cms.T.selected_rapsn_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cms.T.selected_rapsn_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.264C&#x0003e;A</td>
                    <td headers="hd_h_cms.T.selected_rapsn_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn88Lys</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn>
                  <p>NA = not applicable</p>
                </fn>
                <fn id="cms.TF.6.1">
                  <label>1. </label>
                  <p>Variant designation that does not conform to current naming conventions</p>
                </fn>
                <fn id="cms.TF.6.2">
                  <label>2. </label>
                  <p>Promoter mutations. Number of nucleotides 5' of the ATG translation initiation codon</p>
                </fn>
                <fn id="cms.TF.6.3">
                  <label>3. </label>
                  <p>An E-box pathogenic variant, c.-210A&#x0003e;G observed in the homozygous state, arose from a common founder in Near-Eastern Jews with marked jaw and other facial malformations [<xref ref-type="bibr" rid="cms.REF.ohno.2003.739">Ohno et al 2003</xref>].</p>
                </fn>
                <fn id="cms.TF.6.4">
                  <label>4. </label>
                  <p>Alias designations are number of nucleotides 5&#x02019; of the transcription start site.</p>
                </fn>
                <fn id="cms.TF.6.5">
                  <label>5. </label>
                  <p>One E-box pathogenic variant, c.-199C&#x0003e;G, was compound heterozygous with the c.264C&#x0003e;A pathogenic variant [<xref ref-type="bibr" rid="cms.REF.ohno.2003.739">Ohno et al 2003</xref>].</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> Rapsyn, a 43-kd postsynaptic protein, plays an essential role in the clustering of AChR at the endplate. It self-associates, aggregates AChRs, and links them to the subsynaptic cytoskeleton.</p>
            <p><bold>Abnormal gene product.</bold> EP studies in each case have shown decreased staining for rapsyn and AChR, as well as impaired postsynaptic development. Expression studies of mutated constructs indicate that many pathogenic variants diminished co-clustering of AChR with rapsyn. For some missense variants, however, different pathogenic mechanisms that inhibited self-association of rapsyn or reduced the stability of the rapsyn protein have been discovered [<xref ref-type="bibr" rid="cms.REF.cossins.2006.2773">Cossins et al 2006</xref>].</p>
          </sec>
          <sec id="cms.Less_Common_Genetic_Causes_of_CMS">
            <title>Less Common Genetic Causes of CMS</title>
            <p>Click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="cms-less_common_genes.pdf" content-type="local-data">here</inline-supplementary-material> (pdf) for more detailed information on select genes from <xref ref-type="table" rid="cms.T.molecular_genetics_congenital_myas">Table 1b</xref>.</p>
          </sec>
        </sec>
      </sec>
      <sec id="cms.References">
        <title>References</title>
        <sec id="cms.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="cms.Literature_Cited.reflist0">
            <ref id="cms.REF.abicht.2012.1474">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dusl</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallenm&#x000fc;ller</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guergueltcheva</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schara</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Della Marina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wibbeler</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Almaras</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mihaylova</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von der Hagen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huebner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaouch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Congenital myasthenic syndromes: achievements and limitations of phenotype-guided gene-after-gene sequencing in diagnostic practice: a study of 680 patients.</article-title>
                <source>Hum Mutat.</source>
                <year>2012</year>
                <volume>33</volume>
                <fpage>1474</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">22678886</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.abicht.1999.1564">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stucka</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karcagi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herczegfalvi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schara</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramaekers</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jost</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janssen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seidel</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlotter</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller-Felber</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pongratz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochmuller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>A common mutation (epsilon1267delG) in congenital myasthenic patients of Gypsy ethnic origin.</article-title>
                <source>Neurology</source>
                <volume>53</volume>
                <fpage>1564</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10534268</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.abicht.2002.1005">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stucka</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briguet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopfner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>IH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pongratz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller-Felber</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruegg</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochmuller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>A newly identified chromosomal microdeletion and an N-box mutation of the AChR epsilon gene cause a congenital myasthenic syndrome.</article-title>
                <source>Brain</source>
                <volume>125</volume>
                <fpage>1005</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">11960891</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.basiri.2013.469">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Basiri</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belaya</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maxwell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sedghi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Clinical features in a large Iranian family with a limb-girdle congenital myasthenic syndrome due to a mutation in DPAGT1.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2013</year>
                <volume>23</volume>
                <fpage>469</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">23591138</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.beeson.2005.498">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hantai</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochmuller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>126th International Workshop: congenital myasthenic syndromes, 24-26 September 2004, Naarden, the Netherlands.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>15</volume>
                <fpage>498</fpage>
                <lpage>512</lpage>
                <pub-id pub-id-type="pmid">15951177</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.beeson.2006.1975">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higuchi</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palace</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossins</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spearman</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maxwell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newsom-Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burke</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fawcett</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Motomura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slater</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamanashi</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Dok-7 mutations underlie a neuromuscular junction synaptopathy.</article-title>
                <source>Science</source>
                <volume>313</volume>
                <fpage>1975</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16917026</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.belaya.2012a.29">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Belaya</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finlayson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossins</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maxwell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palace</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.</article-title>
                <source>Ann N Y Acad Sci.</source>
                <year>2012a</year>
                <volume>1275</volume>
                <fpage>29</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">23278575</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.belaya.2012b.193">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Belaya</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finlayson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slater</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossins</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maxwell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGowan</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maslau</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Twigg</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walls</surname>
                    <given-names>TJ</given-names>
                  </name>
                </person-group>
                <article-title>Pascual Pascual SI, Palace J, Beeson D. Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2012b</year>
                <volume>91</volume>
                <fpage>193</fpage>
                <lpage>201</lpage>
                <pub-id pub-id-type="pmid">22742743</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.belaya.2015.2493">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Belaya</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodr&#x000ed;guez Cruz</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maxwell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGowan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrugia</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petty</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walls</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sedghi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Basiri</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yue</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarkozy</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertoli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pitt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennett</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaefer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parton</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palace</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D.</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies.</article-title>
                <source>Brain.</source>
                <year>2015</year>
                <volume>138</volume>
                <fpage>2493</fpage>
                <lpage>504</lpage>
                <pub-id pub-id-type="pmid">26133662</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.ben_ammar.2010.754">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ben Ammar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petit</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alexandri</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaudon</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauch&#x000e9;</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouche</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gras</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fournier</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenig</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stojkovic</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacour</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petiot</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zagnoli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viollet</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellegrini</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orlikowski</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lazaro</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoltenburg</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paturneau-Jouas</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sternberg</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanta&#x000ef;</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7.</article-title>
                <source>J Neurol</source>
                <volume>257</volume>
                <fpage>754</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">20012313</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.bergamin.2010.100">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bergamin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hallock</surname>
                    <given-names>PT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burden</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hubbard</surname>
                    <given-names>SR</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerization.</article-title>
                <source>Mol Cell</source>
                <volume>39</volume>
                <fpage>100</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20603078</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.bestuecardiel.2005.144">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bestue-Cardiel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000e1;enz de Cabez&#x000f3;n-Alvarez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capablo-Liesa</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f3;pez-Pis&#x000f3;n</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pe&#x000f1;a-Segura</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin-Martinez</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Congenital endplate acetylcholinesterase deficiency responsive to ephedrine.</article-title>
                <source>Neurology.</source>
                <volume>65</volume>
                <fpage>144</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16009904</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.brownlow.2001.125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brownlow</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webster</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Croxen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brydson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neville</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newsom-Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Acetylcholine receptor delta subunit mutations underlie a fast-channel myasthenic syndrome and arthrogryposis multiplex congenita.</article-title>
                <source>J Clin Invest</source>
                <volume>108</volume>
                <fpage>125</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">11435464</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.burke.2013.170">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Burke</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiscock</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niks</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Main</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manzur</surname>
                    <given-names>AY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ng</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vile</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robb</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2013</year>
                <volume>23</volume>
                <fpage>170</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">23219351</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.burke.2003.826">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Burke</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossins</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maxwell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Owens</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robb</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicolle</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hilton-Jones</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newsom-Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palace</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes.</article-title>
                <source>Neurology</source>
                <volume>61</volume>
                <fpage>826</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14504330</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.burke.2004.356">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Burke</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossins</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maxwell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robb</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicolle</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newsom-Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palace</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Distinct phenotypes of congenital acetylcholine receptor deficiency.</article-title>
                <source>Neuromuscul Disord.</source>
                <volume>14</volume>
                <fpage>356</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">15145336</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.byring.2002.548">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Byring</surname>
                    <given-names>RF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pihko</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsujino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>XM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gustafsson</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hackman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Udd</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Congenital myasthenic syndrome associated with episodic apnea and sudden infant death.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>12</volume>
                <fpage>548</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">12117478</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.chaouch.2012a.566">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chaouch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanta&#x000ef;</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2012a</year>
                <article-title>186th ENMC International Workshop: Congenital myasthenic syndromes 24-26 June 2011, Naarden, The Netherlands.</article-title>
                <source>Neuromuscul Disord.</source>
                <volume>22</volume>
                <fpage>566</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">22230109</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.chaouch.2012b.474">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chaouch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guergueltcheva</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dusl</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schara</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rakocevi&#x00107;-Stojanovi&#x00107;</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindberg</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scola</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Werneck</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colomer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nascimento</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilchez</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muelas</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Argov</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2012b</year>
                <article-title>A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome.</article-title>
                <source>J Neurol.</source>
                <volume>259</volume>
                <fpage>474</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">21822932</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.chaouch.2014.75">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chaouch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porcelli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edvardson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scarcia</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Grassi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierri</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossins</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laval</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evangelista</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>T&#x000f6;pf</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huebner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von der Hagen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elpeleg</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palace</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senderek</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmieri</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the mitochondrial citrate carrier SLC25A1 are associated with impaired neuromuscular transmission.</article-title>
                <source>J Neuromuscul Dis.</source>
                <year>2014</year>
                <volume>1</volume>
                <fpage>75</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">26870663</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.chevessier.2004.3229">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chevessier</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faraut</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravel-Chapuis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaudon</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauche</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prioleau</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herbst</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goillot</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ioos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azulay</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attarian</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leroy</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fournier</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legay</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaeffer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenig</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pouget</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hantai</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>MUSK, a new target for mutations causing congenital myasthenic syndrome.</article-title>
                <source>Hum Mol Genet</source>
                <volume>13</volume>
                <fpage>3229</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">15496425</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.colomer.2006.329">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Colomer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vernet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nascimento</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pons</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzalez</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Long-term improvement of slow-channel congenital myasthenic syndrome with fluoxetine.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>16</volume>
                <fpage>329</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">16621558</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.cossins.2013.944">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cossins</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belaya</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hicks</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salih</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finlayson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carboni</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maxwell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zoltowska</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farsani</surname>
                    <given-names>GT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laval</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seidhamed</surname>
                    <given-names>MZ</given-names>
                  </name>
                  <collab>WGS500 Consortium</collab>
                </person-group>
                <article-title>Donnelly P, Bentley D, McGowan SJ, M&#x000fc;ller J, Palace J, Lochm&#x000fc;ller H, Beeson D. Congenital myasthenic syndromes due to mutations in ALG2 and ALG14.</article-title>
                <source>Brain.</source>
                <year>2013</year>
                <volume>136</volume>
                <fpage>944</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">23404334</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.cossins.2006.2773">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cossins</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burke</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maxwell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spearman</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Man</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuks</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palace</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuhrer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutations.</article-title>
                <source>Brain</source>
                <volume>129</volume>
                <fpage>2773</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">16945936</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.croxen.2002a.162">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Croxen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hatton</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shelley</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brydson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chauplannaz</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oosterhuis</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newsom-Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colquhoun</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2002a</year>
                <article-title>Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes.</article-title>
                <source>Neurology</source>
                <volume>59</volume>
                <fpage>162</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12141316</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.croxen.2009.294">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Croxen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hatton</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shelley</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brydson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chauplannaz</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oosterhuis</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newsom-Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colquhoun</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Voluntary partial retraction of: Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes.</article-title>
                <source>Neurology.</source>
                <year>2009</year>
                <volume>72</volume>
                <fpage>294</fpage>
                <pub-id pub-id-type="pmid">19153382</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.croxen.1997.767">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Croxen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newland</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oosterhuis</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chauplannaz</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newsom-Davis</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome.</article-title>
                <source>Hum Mol Genet</source>
                <volume>6</volume>
                <fpage>767</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">9158151</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.croxen.2002b.1563">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Croxen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newsom-Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2002b</year>
                <article-title>Myasthenia gravis in a woman with congenital AChR deficiency due to epsilon-subunit mutations.</article-title>
                <source>Neurology</source>
                <volume>58</volume>
                <fpage>1563</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12034803</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.deymeer.1999.129">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Deymeer</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serdaroglu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozdemir</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Familial infantile myasthenia: confusion in terminology.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>9</volume>
                <fpage>129</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">10382904</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.donger.1998.967">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Donger</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krejci</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serradell</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bon</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicole</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chateau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gary</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Massoulie</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guicheney</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic).</article-title>
                <source>Am J Hum Genet</source>
                <volume>63</volume>
                <fpage>967</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">9758617</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.engel.2007.252">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The therapy of congenital myasthenic syndromes.</article-title>
                <source>Neurotherapeutics</source>
                <volume>4</volume>
                <fpage>252</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17395135</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.engel.2003.339">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sine</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <article-title>Sleuthing molecular targets for neurological diseases at the neuromuscular junction.</article-title>
                <source>Nat Rev Neurosci.</source>
                <year>2003</year>
                <volume>4</volume>
                <fpage>339</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">12728262</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.engel.2015.461">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>XM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selcen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sine</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment.</article-title>
                <source>Lancet Neurol</source>
                <volume>14</volume>
                <fpage>461</fpage>
                <pub-id pub-id-type="pmid">25895926</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.engel.2005.308">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sine</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Current understanding of congenital myasthenic syndromes.</article-title>
                <source>Curr Opin Pharmacol</source>
                <volume>5</volume>
                <fpage>308</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">15907919</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.fattahi.2015.60">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fattahi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kahrizi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nafissi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fadaee</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abedini</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kariminejad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akbari</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Najmabadi</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Report of a patient with limb-girdle muscular dystrophy, ptosis and ophthalmoparesis caused by plectinopathy.</article-title>
                <source>Arch Iran Med.</source>
                <year>2015</year>
                <volume>18</volume>
                <fpage>60</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">25556389</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.finlayson.2013.80">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Finlayson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palace</surname>
                    <given-names>J.</given-names>
                  </name>
                </person-group>
                <article-title>Congenital myasthenic syndromes: an update.</article-title>
                <source>Pract Neurol.</source>
                <year>2013</year>
                <volume>13</volume>
                <fpage>80</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">23468559</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.forrest.2010.709">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Forrest</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robb</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dopping-Hepenstal</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buk</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Sarraj</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wraige</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Congenital muscular dystrophy, myasthenic symptoms and epidermolysis bullosa simplex (EBS) associated with mutations in the PLEC1 gene encoding plectin.</article-title>
                <source>Neuromuscul Disord.</source>
                <volume>20</volume>
                <fpage>709</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">20624679</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.ganetzky.2015.2411">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ganetzky</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Izumi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edmondson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muraresku</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zackai</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deardorff</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganesh</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Fetal akinesia deformation sequence due to a congenital disorder of glycosylation.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2015</year>
                <volume>167A</volume>
                <fpage>2411</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">26033833</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.gaudon.2010.795">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gaudon</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;nisson-Besnier</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabrol</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouhour</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demay</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben Ammar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauch&#x000e9;</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vial</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicolas</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanta&#x000ef;</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Multiexon deletions account for 15% of congenital myasthenic syndromes with RAPSN mutations after negative DNA sequencing.</article-title>
                <source>J Med Genet</source>
                <volume>47</volume>
                <fpage>795</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20930056</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.guergueltcheva.2012.838">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guergueltcheva</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dusl</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senderek</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oldfors</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindbergh</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maxwell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colomer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mallebrera</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nascimento</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilchez</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muelas</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nafissi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kariminejad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nilipour</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bozorgmehr</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Najmabadi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodolico</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sieb</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlotter</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schoser</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herrmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voit</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinlein</surname>
                    <given-names>OK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Najafi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soler</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanna</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaouch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palace</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations.</article-title>
                <source>J Neurol.</source>
                <year>2012</year>
                <volume>259</volume>
                <fpage>838</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">21975507</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.habbout.2016.161">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Habbout</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poulin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivier</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giuliano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sternberg</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontaine</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morales</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Echenne</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanna</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e4;nnikk&#x000f6;</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chahine</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicole</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bendahhou</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>A recessive Nav1.4 mutation underlies congenital myasthenic syndrome with periodic paralysis.</article-title>
                <source>Neurology.</source>
                <year>2016</year>
                <volume>86</volume>
                <fpage>161</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">26659129</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.hanta_.2013.561">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hanta&#x000ef;</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicole</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B.</given-names>
                  </name>
                </person-group>
                <article-title>Congenital myasthenic syndromes: an update.</article-title>
                <source>Curr Opin Neurol.</source>
                <year>2013</year>
                <volume>26</volume>
                <fpage>561</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23995276</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.hanta_.2004.539">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hanta&#x000ef;</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenig</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B.</given-names>
                  </name>
                </person-group>
                <article-title>Congenital myasthenic syndromes.</article-title>
                <source>Curr Opin Neurol.</source>
                <year>2004</year>
                <volume>17</volume>
                <fpage>539</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">15367858</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.harper.1998.480">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harper</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome.</article-title>
                <source>Ann Neurol</source>
                <volume>43</volume>
                <fpage>480</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">9546329</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.harper.2003.1710">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harper</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukodome</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Treatment of slow-channel congenital myasthenic syndrome with fluoxetine.</article-title>
                <source>Neurology</source>
                <volume>60</volume>
                <fpage>1710</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">12771277</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.herrmann.2014.332">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Herrmann</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sowden</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzalez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanchez-Mejias</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guan</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whittaker</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Almodovar</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bansagi</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pyle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boczonadi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lloyd</surname>
                    <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Littleton</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuchner</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Synaptotagmin 2 mutations cause an autosomal-dominant form of lambert-eaton myasthenic syndrome and nonprogressive motor neuropathy.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2014</year>
                <volume>95</volume>
                <fpage>332</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">25192047</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.hoch.2001.365">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hoch</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McConville</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helms</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newsom-Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melms</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.</article-title>
                <source>Nat Med</source>
                <volume>7</volume>
                <fpage>365</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11231638</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.huz_.2009.155">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huz&#x000e9;</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauch&#x000e9;</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chevessier</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goillot</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaudon</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben Ammar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaboud</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grosjean</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lecuyer</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouche</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alexandri</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuntzer</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fournier</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brancaccio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000fc;egg</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenig</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaeffer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanta&#x000ef;</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Identification of an agrin mutation that causes congenital myasthenia and affects synapse function.</article-title>
                <source>Am J Hum Genet</source>
                <volume>85</volume>
                <fpage>155</fpage>
                <lpage>67</lpage>
                <pub-id pub-id-type="pmid">19631309</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.jurkatrott.2010.239">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jurkat-Rott</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holzherr</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fauler</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann-Horn</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Sodium channelopathies of skeletal muscle result from gain or loss of function.</article-title>
                <source>Pflugers Arch.</source>
                <volume>460</volume>
                <fpage>239</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">20237798</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.karakaya.2014">
              <mixed-citation publication-type="confproc">Karakaya M, Ceyhan-Birsoy O, Beggs AH, Topaloglu H. A novel missense mutation in the AGRN gene causing congenital myasthenic syndrome mimicking neck myopathy. Berlin, Germany: 19th International Congress of the World-Muscle-Society. 2014.</mixed-citation>
            </ref>
            <ref id="cms.REF.karcagi.2001.231">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Karcagi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournev</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herczegfalvi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guergueltcheva</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Litvinenko</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>IH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochmuller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Congenital myasthenic syndrome in southeastern European Roma (Gypsies).</article-title>
                <source>Acta Myologica</source>
                <volume>20</volume>
                <fpage>231</fpage>
                <lpage>8</lpage>
              </element-citation>
            </ref>
            <ref id="cms.REF.kinali.2008.6">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kinali</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pitt</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simonds</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aloysius</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cockerill</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palace</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manzur</surname>
                    <given-names>AY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jimenez-Mallebrera</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robb</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Congenital myasthenic syndromes in childhood: diagnostic and management challenges.</article-title>
                <source>J Neuroimmunol</source>
                <volume>201-202</volume>
                <fpage>6</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">18707767</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.lashley.2010.1517">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lashley</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palace</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jayawant</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robb</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.</article-title>
                <source>Neurology</source>
                <volume>74</volume>
                <fpage>1517</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">20458068</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.liewluck.2011.789">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liewluck</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selcen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and Dok-7 myasthenia.</article-title>
                <source>Muscle Nerve</source>
                <volume>44</volume>
                <fpage>789</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">21952943</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.logan.2015.878">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Logan</surname>
                    <given-names>CV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossins</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodr&#x000ed;guez Cruz</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parry</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maxwell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez-Mart&#x000ed;nez</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riepsaame</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdelhamed</surname>
                    <given-names>ZA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lake</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moran</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robb</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chow</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopkins</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheridan</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jayawant</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palace</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Congenital myasthenic syndrome type 19 is caused by mutations in COL13A1, encoding the atypical non-fibrillar collagen type XIII &#x003b1;1 chain.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2015</year>
                <volume>97</volume>
                <fpage>878</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">26626625</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.lorenzoni.2013.155">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lorenzoni</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scola</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kay</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filla</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miranda</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinheiro</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaouch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Werneck</surname>
                    <given-names>LC</given-names>
                  </name>
                </person-group>
                <article-title>Salbutamol therapy in congenital myasthenic syndrome due to DOK7 mutation.</article-title>
                <source>J Neurol Sci.</source>
                <year>2013</year>
                <volume>331</volume>
                <fpage>155</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">23790237</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.maselli.2010.2370">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maselli</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arredondo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cagney</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ng</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerke</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soliven</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wollmann</surname>
                    <given-names>RL</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction.</article-title>
                <source>Hum Mol Genet</source>
                <volume>19</volume>
                <fpage>2370</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20371544</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.maselli.2012.1123">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maselli</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandez</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arredondo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Navarro</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ngo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cagney</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wollmann</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yarov-Yarovoy</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferns</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>LG2 agrin mutation causing severe congenital myasthenic syndrome mimics functional characteristics of non-neural (z-) agrin.</article-title>
                <source>Hum Genet.</source>
                <year>2012</year>
                <volume>131</volume>
                <fpage>1123</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">22205389</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.maselli.2009.203">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maselli</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ng</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cagney</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arredondo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wessel</surname>
                    <given-names>HB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdel-Hamid</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wollmann</surname>
                    <given-names>RL</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome.</article-title>
                <source>J Med Genet</source>
                <volume>46</volume>
                <fpage>203</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19251977</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.mihaylova.2009.1926">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mihaylova</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salih</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukhtar</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abuzeid</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Sadig</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von der Hagen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huebner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000fc;rnberg</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guergueltcheva</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Refinement of the clinical phenotype in musk-related congenital myasthenic syndromes.</article-title>
                <source>Neurology</source>
                <volume>73</volume>
                <fpage>1926</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19949040</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.milone.1999.a188">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Milone</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>XM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harper</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukudome</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stilling</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brengman</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Unusual congenital myasthenic syndrome (CMS) with endplate AChR deficiency caused by alpha- subunit mutations and a remitting-relapsing clinical course.</article-title>
                <source>Neurology</source>
                <volume>52</volume>
                <fpage>A188</fpage>
              </element-citation>
            </ref>
            <ref id="cms.REF.milone.2009.228">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Milone</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>XM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selcen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brengman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iannaccone</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harper</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patients.</article-title>
                <source>Neurology.</source>
                <volume>73</volume>
                <fpage>228</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">19620612</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.monies.2014.353">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Monies</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Hindi</surname>
                    <given-names>HN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Muhaizea</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaroudi</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Younes</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naim</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakil</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>BF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bohlega</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and pathological heterogeneity of a congenital disorder of glycosylation manifesting as a myasthenic/myopathic syndrome.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2014</year>
                <volume>24</volume>
                <fpage>353</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24461433</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.morar.2004.596">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morar</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gresham</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelicheva</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournev</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gooding</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guergueltcheva</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochmuller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tordai</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalmar</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karcagi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeanpierre</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herczegfalvi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venkataraman</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warwick Carter</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reeve</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Pablo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kucinskas</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalaydjieva</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutation history of the roma/gypsies.</article-title>
                <source>Am J Hum Genet</source>
                <volume>75</volume>
                <fpage>596</fpage>
                <lpage>609</lpage>
                <pub-id pub-id-type="pmid">15322984</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.m_ller.2004a.e104">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burke</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossins</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumeister</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stucka</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hantai</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochmuller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2004a</year>
                <article-title>The Congenital Myasthenic Syndrome mutation RAPSN N88K derives from an ancient Indo-European founder.</article-title>
                <source>J Med Genet</source>
                <volume>41</volume>
                <fpage>e104</fpage>
                <pub-id pub-id-type="pmid">15286164</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.m_ller.2004b.744">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christen</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stucka</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schara</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huebner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochmuller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2004b</year>
                <article-title>A newly identified chromosomal microdeletion of the rapsyn gene causes a congenital myasthenic syndrome.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>14</volume>
                <fpage>744</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15482960</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.m_ller.2006.2784">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumeister</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schara</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossins</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krause</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von der Hagen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huebner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webster</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn.</article-title>
                <source>Brain</source>
                <volume>129</volume>
                <fpage>2784</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">16916845</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.m_ller.2007a.1497">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herczegfalvi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilchez</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colomer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bachinski</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mihaylova</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santos</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schara</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deschauer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shevell</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poulin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dias</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soudo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hietala</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>A&#x000e4;rimaa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krahe</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karcagi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huebner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2007a</year>
                <article-title>Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes.</article-title>
                <source>Brain</source>
                <volume>130</volume>
                <fpage>1497</fpage>
                <lpage>506</lpage>
                <pub-id pub-id-type="pmid">17439981</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.m_ller.2007b.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mihaylova</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2007b</year>
                <article-title>Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission.</article-title>
                <source>Expert Rev Mol Med.</source>
                <volume>9</volume>
                <fpage>1</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">17686188</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.nichols.1999.439">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nichols</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Croxen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rutter</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutchinson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newsom-Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Mutation of the acetylcholine receptor epsilon-subunit promoter in congenital myasthenic syndrome.</article-title>
                <source>Ann Neurol</source>
                <volume>45</volume>
                <fpage>439</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">10211467</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.nicole.2014.2429">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nicole</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaouch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torbergsen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauch&#x000e9;</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Bruyckere</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontenille</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horn</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Ghelue</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f8;seth</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Issop</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evangelista</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St&#x000e5;lberg</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ioos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barois</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brochier</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sternberg</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fournier</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanta&#x000ef;</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dusl</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laval</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy.</article-title>
                <source>Brain.</source>
                <year>2014</year>
                <volume>137</volume>
                <fpage>2429</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">24951643</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.niimi.2001.566">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Niimi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogawara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueyama</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kambe</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okamoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ban</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamanoi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozaki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujiwara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukui</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>EI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kyushiki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanigami</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Identification of GFAT1-L, a novel splice variant of human glutamine: fructose-6-phosphate amidotransferase (GFAT1) that is expressed abundantly in skeletal muscle.</article-title>
                <source>J Hum Genet.</source>
                <volume>46</volume>
                <fpage>566</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">11587069</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.ohkawara.2014.1856">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohkawara</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabrera-Serrano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milone</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asai</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masuda</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>LRP4 third &#x003b2;-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2014</year>
                <volume>23</volume>
                <fpage>1856</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">24234652</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.ohno.1999.131">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anlar</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Congenital myasthenic syndrome caused by a mutation in the Ets-binding site of the promoter region of the acetylcholine receptor epsilon subunit gene.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>9</volume>
                <fpage>131</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10382905</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.ohno.1998.9654">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brengman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsujino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>95</volume>
                <fpage>9654</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9689136</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.ohno.2004a.117">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>2004a</year>
                <article-title>Congenital myasthenic syndromes: gene mutations.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>14</volume>
                <fpage>117</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">14702950</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.ohno.2004b.e8">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>2004b</year>
                <article-title>Lack of founder haplotype for the rapsyn mutation; N88K is an ancient founder mutation or arises from multiple founders.</article-title>
                <source>J Med Genet</source>
                <volume>41</volume>
                <fpage>e8</fpage>
                <pub-id pub-id-type="pmid">14729848</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.ohno.2000.162">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brengman</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>XM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heidenreich</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milone</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demirci</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akiguchi</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>The spectrum of mutations causing end-plate acetylcholinesterase deficiency.</article-title>
                <source>Ann Neurol</source>
                <volume>47</volume>
                <fpage>162</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">10665486</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.ohno.2002.875">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>XM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selcen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brengman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harper</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsujino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milone</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome.</article-title>
                <source>Am J Hum Genet</source>
                <volume>70</volume>
                <fpage>875</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">11791205</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.ohno.2003.739">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadeh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blatt</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brengman</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>E-box mutations in the RAPSN promoter region in eight cases with congenital myasthenic syndrome.</article-title>
                <source>Hum Mol Genet</source>
                <volume>12</volume>
                <fpage>739</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">12651869</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.ohno.2001.2017">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsujino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brengman</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harper</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bajzer</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Udd</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beyring</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robb</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirkham</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>98</volume>
                <fpage>2017</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">11172068</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.okada.2006.1802">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Okada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murata</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kakuta</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jigami</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiraishi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eguchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Motomura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akiyama</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwakura</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higuchi</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamanashi</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>The muscle protein Dok-7 is essential for neuromuscular synaptogenesis.</article-title>
                <source>Science.</source>
                <volume>312</volume>
                <fpage>1802</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16794080</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.palace.2007.1507">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Palace</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lashley</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newsom-Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossins</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maxwell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennett</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jayawant</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamanashi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Clinical features of the DOK7 neuromuscular junction synaptopathy.</article-title>
                <source>Brain</source>
                <volume>130</volume>
                <fpage>1507</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">17452375</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.quiram.1999.1403">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Quiram</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milone</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pruitt</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brengman</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sine</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Mutation causing congenital myasthenia reveals acetylcholine receptor beta/delta subunit interaction essential for assembly.</article-title>
                <source>J Clin Invest.</source>
                <volume>104</volume>
                <fpage>1403</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">10562302</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.ravenscroft.2011.793">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ravenscroft</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sollis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charles</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>North</surname>
                    <given-names>KN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baynam</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laing</surname>
                    <given-names>NG</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Fetal akinesia: review of the genetics of the neuromuscular causes.</article-title>
                <source>J Med Genet.</source>
                <volume>48</volume>
                <fpage>793</fpage>
                <lpage>801</lpage>
                <pub-id pub-id-type="pmid">21984750</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.r_gal.2014.1254">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>R&#x000e9;gal</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>XM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selcen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verhille</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meulemans</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Creemers</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <article-title>PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome.</article-title>
                <source>Neurology.</source>
                <year>2014</year>
                <volume>82</volume>
                <fpage>1254</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">24610330</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.richard.2003.e81">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaudon</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreux</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasaki</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prioleau</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauche</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barois</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ioos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Routon</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mokhtari</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leroy</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fournier</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hainque</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenig</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hantai</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Possible founder effect of rapsyn N88K mutation and identification of novel rapsyn mutations in congenital myasthenic syndromes.</article-title>
                <source>J Med Genet</source>
                <volume>40</volume>
                <fpage>e81</fpage>
                <pub-id pub-id-type="pmid">12807980</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.rodr_guez_cruz.2014.2234">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rodr&#x000ed;guez Cruz</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palace</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Inherited disorders of the neuromuscular junction: an update.</article-title>
                <source>J Neurol</source>
                <volume>261</volume>
                <fpage>2234</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">25305004</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.schara.2009.828">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schara</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barisic</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deschauer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindberg</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strigl-Pill</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wendt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>19</volume>
                <fpage>828</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">19837590</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.schara.2012.184">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schara</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Della Marina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A.</given-names>
                  </name>
                </person-group>
                <article-title>Congenital myasthenic syndromes: current diagnostic and therapeutic approaches.</article-title>
                <source>Neuropediatrics.</source>
                <year>2012</year>
                <volume>43</volume>
                <fpage>184</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">22911480</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.selcen.2014.1822">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Selcen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>XM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brengman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stans</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wieben</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>DPAGT1 myasthenia and myopathy: genetic, phenotypic, and expression studies.</article-title>
                <source>Neurology</source>
                <volume>82</volume>
                <fpage>1822</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">24759841</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.selcen.2011.327">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Selcen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Juel</surname>
                    <given-names>VC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hobson-Webb</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stickler</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bite</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Myasthenic syndrome caused by plectinopathy.</article-title>
                <source>Neurology</source>
                <volume>76</volume>
                <fpage>327</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">21263134</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.selcen.2015.889">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Selcen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohkawara</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>XM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McEvoy</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Impaired synaptic development, maintenance, and neuromuscular transmission in LRP4-related myasthenia.</article-title>
                <source>JAMA Neurol</source>
                <volume>72</volume>
                <fpage>889</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">26052878</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.senderek.2011.162">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Senderek</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dusl</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strom</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guergueltcheva</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diepolder</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laval</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maxwell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossins</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krause</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muelas</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilchez</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colomer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mallebrera</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nascimento</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nafissi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kariminejad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nilipour</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bozorgmehr</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Najmabadi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodolico</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sieb</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinlein</surname>
                    <given-names>OK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlotter</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schoser</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herrmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voit</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oldfors</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindbergh</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von der Hagen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000fc;bner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palace</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect.</article-title>
                <source>Am J Hum Genet</source>
                <volume>88</volume>
                <fpage>162</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">21310273</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.servais.2013.815">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Servais</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baudoin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zehrouni</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sternberg</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fournier</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stojkovic</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Pregnancy in congenital myasthenic syndrome.</article-title>
                <source>J Neurol</source>
                <volume>260</volume>
                <fpage>815</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23108489</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.shen.2014.2247">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>XM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selcen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brengman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <article-title>Mutant SNAP25B causes myasthenia, cortical hyperexcitability, ataxia, and intellectual disability.</article-title>
                <source>Neurology.</source>
                <year>2014</year>
                <volume>83</volume>
                <fpage>2247</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">25381298</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.tansindhunata.2015.1151">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tan-Sindhunata</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathijssen</surname>
                    <given-names>IB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smit</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baas</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Voorn</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kluijt</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hagen</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blom</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sistermans</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meijers-Heijboer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waisfisz</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiss</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Groffen</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <article-title>Identification of a Dutch founder mutation in MUSK causing fetal akinesia deformation sequence.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2015</year>
                <volume>23</volume>
                <fpage>1151</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">25537362</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.tsujino.2003.7377">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tsujino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maertens</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>XM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukuda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harper</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cannon</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Myasthenic syndrome caused by mutation of the SCN4A sodium channel.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>100</volume>
                <fpage>7377</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">12766226</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.vogt.2008.222">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vogt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harrison</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spearman</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossins</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>ten Cate</surname>
                    <given-names>LN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>NV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Mutation analysis of CHRNA1, CHRNB1, CHRND, and RAPSN genes in multiple pterygium syndrome/fetal akinesia patients.</article-title>
                <source>Am J Hum Genet</source>
                <volume>82</volume>
                <fpage>222</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18179903</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.vrinten.2014.cd010028">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vrinten</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Zwaag</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weinreich</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholten</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verschuuren</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <article-title>Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes.</article-title>
                <source>Cochrane Database Syst Rev.</source>
                <year>2014</year>
                <issue>12</issue>
                <fpage>CD010028</fpage>
                <pub-id pub-id-type="pmid">25515947</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.whittaker.2015.1964">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Whittaker</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herrmann</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bansagi</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasan</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lofra</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Logigian</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sowden</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Almodovar</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Littleton</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuchner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Electrophysiologic features of SYT2 mutations causing a treatable neuromuscular syndrome.</article-title>
                <source>Neurology.</source>
                <year>2015</year>
                <volume>85</volume>
                <fpage>1964</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">26519543</pub-id>
              </element-citation>
            </ref>
            <ref id="cms.REF.witting.2014.350">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Witting</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vissing</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Pharmacologic treatment of downstream of tyrosine kinase 7 congenital myasthenic syndrome.</article-title>
                <source>JAMA Neurol.</source>
                <year>2014</year>
                <volume>71</volume>
                <fpage>350</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">24425145</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="cms.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="cms.Suggested_Reading.reflist0">
            <ref id="cms.REF.engel.2012.92">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Congenital myasthenic syndromes in 2012.</article-title>
                <source>Curr Neurol Neurosci Rep.</source>
                <volume>12</volume>
                <fpage>92</fpage>
                <lpage>101</lpage>
                <pub-id pub-id-type="pmid">21997714</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="cms.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="cms.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>14 July 2016 (ha) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>28 June 2012 (cd) Revision: targeted mutation analysis of <italic toggle="yes">CHRNA1</italic> no longer listed in the GeneTests&#x02122; Laboratory Directory as being available clinically</p>
            </list-item>
            <list-item>
              <p>22 March 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>26 September 2006 (aa) Revision: clinical testing available for: mutation scanning of <italic toggle="yes">RAPSN</italic>, <italic toggle="yes">CHAT</italic>, <italic toggle="yes">COLQ</italic>, <italic toggle="yes">CHRNB1</italic>, and <italic toggle="yes">CHRND</italic>; sequence analysis of <italic toggle="yes">CHRNE</italic> and <italic toggle="yes">CHRNA1</italic>; targeted mutation analysis of <italic toggle="yes">RAPSN</italic> mutation p.N88K, <italic toggle="yes">CHAT</italic> mutation p.I305T, and <italic toggle="yes">CHRNA1</italic> mutation p.G153S; prenatal diagnosis for <italic toggle="yes">CHAT</italic>, <italic toggle="yes">CHRNA1</italic>, <italic toggle="yes">CHRNB1</italic>, <italic toggle="yes">CHRND</italic>, <italic toggle="yes">CHRNE</italic>, <italic toggle="yes">COLQ</italic>, and <italic toggle="yes">RAPSN</italic></p>
            </list-item>
            <list-item>
              <p>20 September 2005 (aa) Revision: sequence analysis for <italic toggle="yes">RAPSN</italic> clinically available</p>
            </list-item>
            <list-item>
              <p>8 August 2005 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>9 May 2003 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>30 January 2003 (aa) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
